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Neglected tropical diseases (NTD) in low- and middle-income countries are still not on 
target per the World Health Organization’s (WHO) elimination goal of 2020. Mass drug 
administration (MDA) is one of the effective strategies supported by the WHO for the 
control and subsequent elimination of NTD. This quantitative study explored how supply 
chain logistic capacity may be hampering MDA coverage in countries in which the 
diseases are endemic. The study examined secondary data from WHO data bank for 
MDA coverage, to quantify the relationship between supply chain logistics capacity, as 
measured by the World Bank’s logistics performance index (LPIs), and the control of 
NTD using MDA. The ecological theory of health behavior was the theoretical 
framework for this study. The research questions explored whether a low- and/or middle-
income country’s supply chain infrastructure, logistics services, customs and border 
procedures, and supply chain reliability, predict the coverage of MDA in controlling 
NTD. A multiple regression model determined the linear relations between each 
predictor: supply chain infrastructure (H1), logistics services (H2), custom and border 
procedures (H3), and supply chain reliability (H4) and the control of neglected diseases as 
determine by MDA. Results indicated that supply chain capacity, custom and border 
processes, and supply chain reliability are statistically significant in predictors of MDA 
coverage in the control of NTD in developing countries. This study may enhance social 
change by improving supply chain capacity for more effective distribution of PCT drugs, 
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Chapter 1: Introduction to the Study 
 Introduction 
Neglected tropical diseases (NTD) are a group of 17 parasitic, zoonotic, and 
helminthic diseases that affect “the bottom billion” people in mostly poor, developing 
countries (Hotez et al., 2009),. NTDs affect more than 1 billion people in low- and 
middle-income countries, accounting for an annual mortality of over 534,000 deaths 
(Hotez, Fenwick, Savioli, & Molyneux, 2009). Tropical disease control remains a 
challenge due to the limited capacity of low- and middle-income countries to implement 
the effective strategy of preventive chemotherapy and transmission control, PCT, (Zhang, 
MacArthur, Mubila, & Baker, 2010). In recent years however, due to the devastating 
effect of these diseases in endemic communities, international public health support, 
through the World Health Organization (WHO), is being received. The WHO is leading a 
consortium of international organizations, philanthropists, and private pharmaceutical 
companies that form private-public partnerships (PPP) to support research in the control 
and subsequent elimination of NTDs in developing countries (Addiss, 2010). Through 
this partnership, the Global Program for the Elimination of Neglected Tropical Diseases 
(GPENTD) initiative was created in 2000 with the aim of stopping the devastating effect 
of NTD through preventive chemotherapy by MDA (WHO, 2013).  
Research in the control of NTDs shows that PCT, through mass drug 
administration (MDA), is effective in controlling vector transmission and potentially 
eliminating tropical diseases in endemic communities (Keenan et al., 2013). MDA, is the 




irrespective of disease condition, resulting in reduction in blood parasitic population that 
causes disability and mortality  (Keenan et al., 2013). Therefore, annual MDA coverage 
is the indicator of successful control of tropical diseases in endemic communities (Smits, 
2009). For this reason, exploring factors that may mitigate annual coverage of MDA in 
endemic communities may contribute to positive social change of reducing disabilities 
and improving population health in endemic communities. 
Kentel et al., (2013) outlined factors responsible for low intake of MDA in 
endemic communities (Krentel, Fischer, & Weil, 2013), but failed to consider supply 
chain capacity as a possible predictor of NTD control (Lega, Marsilio, & Villa, 2012). 
Even though research has shown a positive correlation between supply chain and 
improved services in business and financial organizations (K. W. Green, Whitten, & 
Inman, 2008), and  in manufacturing and food sectors (Infante & Santos, 2007), its 
relations to public health disease prevention received little attention (Lee, Lee, & 
Schniederjans, 2011; Lega et al., 2012). For instance, Lee et al., (2011) demonstrated that 
supply chain capacity diminishes hospitals’ performance and quality of care (Lee et al., 
2011). Others have shown that stronger supply chains enhance vaccine distribution (Lega 
et al., 2012), rapid response to emergency outbreaks, as well as humanitarian logistics 
(Mbohwa, 2010). Nonetheless, research is  insufficient on the effect of supply chain 
structures in the control of tropical diseases with mass administration of PCT drugs in 
endemic communities (Lee et al., 2011).  
This study was an attempt to fill the existing literature gap in disease prevention 




administration of PCT drugs, in low- and middle-income countries. Because the 
elimination of NTDs depends on MDA coverage (Keenan et al., 2013), factors impacting 
successful MDA coverage may have rippling effects on eradication. Consequently, 
ecological structures that mitigate the effective distribution of chemotherapeutic drugs to 
affected communities needs to be strengthened (Baker et al., 2013).  Because supply 
chain logistics is a set of activities linked to downstream distribution of products and to 
the upstream flow of information from manufacturers to end users (Lee et al., 2011), 
there is a potential association between supply chain capacity and NTD elimination. 
Therefore, exploring this association may help public health practitioners, policymakers, 
researchers, and developing country program managers craft appropriate strategies 
toward NTD elimination.  
This study is expected to contribute to social change through interventions related 
the supply chain, which, when implemented, would strengthen ecological predictors 
impacting elimination of NTD in LMIC. Additionally, this study is expected to broaden 
scientific knowledge in disease prevention beyond the traditional scope of epidemiology, 
to fill the gap in crafting effective measures toward NTD elimination.  
Background     
Research in the application of supply chain to disease prevention has received 
limited attention by public health practitioners (Elmuti, Khoury, Omran, & Abou-Zaid, 
2013; Lee et al., 2011). Reasons for insufficient attention are as follows: it consists of 
multidisciplinary subject matter (de Vries, & Huijsman, 2011), fragmented theories 




among public health practitioners (Elmuti et al., 2013). In recent years however, supply 
chain research has received attention in the healthcare sector with respect to information 
technology, supply chain innovation, agile management processes and performance 
matrices (de Vries et al., 2011). Nonetheless, fragmented theoretical frameworks in 
supply-chain research make direct transfer of knowledge from business and economics to 
epidemiology, a complex undertaking (de Vries et al., 2011).  
In a systematic literature review of 638 published supply chain articles, more than 
181 theories were used to develop hypotheses, research questions, and models (Defee et 
al., 2010). Thus, the theoretical diversities in supply chain research, which are mostly 
outside traditional epidemiology, put a unique perspective on the application of supply 
chain principles to disease prevention. Furthermore, fragmented theories created 
upstream and downstream constraints in measuring the effectiveness of supply chain 
interventions to disease prevention (Chen & Paulraj, 2004). Therefore, innovative 
research methods are needed to define measurable constructs that relate supply chain to 
disease prevention, particularly for the elimination of tropical disease in low- and middle-
income countries.  
Building on the existing constructs of supply chain performance in business and 
economics, this research explored how supply chain capacities can predict NTD control 
in low- and middle-income countries. To assess  worldwide supply chain capacities, the 
World Bank developed the logistics performance index (LPI), which is a series of 
indicators that measure national structures that impact the ease of products movements 




Since 2007, the World Bank has collected LPI for more than 160 countries across the 
globe, including LMIC, to assess logistics capacities in the distribution of essential 
products to end-users (Martí, Puertas, & García, 2014). 
Low- and middle-income countries account for 85% of the global burden of NTD 
responsible for 22 million disability-adjusted life years (DALY) annually (Hotez & 
Kamath, 2009). Control of NTDs in LMIC-endemic countries is measured by the 
successful implementation of PCT using MDA (Keenan et al., 2013). Repeated MDAs in 
endemic communities has been shown to substantially reduce blood microfilariae (24.5 to 
2.7%), felarial antigen (53.3 to 19.6%), and antibodies to filarial antigen (78.9 to 27.5%) 
in the control of lymphatic filariasis in Tanzania (Simonsen et al., 2013). As a result, 
repeated administration of preventive chemotherapy significantly reduces infectious 
agents leading to the control and elimination of tropical diseases in some countries. 
Nonetheless, LMIC continue to record low MDA coverage as a result of inadequate 
ecological structures to successfully implement PCT interventions (Krentel et al., 2013). 
This study explored the ecological relationship between supply-chain capacity 
and control of tropical diseases by MDA in developing countries. The study also 
reviewed gaps in the current literature on best approaches to eliminate NTD by 
examining supply chain logistics management in low- and middle-income countries 
(Spiegel et al., 2010).  
Literature on supply chain research from industrial, economic, and the private 
sector was borrowed into public health to explore how supply chain structures predict 




expected to benefit policymakers, international organizations and academia in their quest 
to understand mitigating factors in the control of tropical diseases.  
This study, therefore, delineated the importance of supply chain in disease 
prevention, which has been minimally explored in public health research. The social 
change implication of this research is as follows: strengthened supply chain 
infrastructure; improved border processes; reliable logistics services; and reduced 
disability and mortality of NTD in affected communities.   
Problem Statement 
Control of NTDs relative to the availability of chemotherapeutic drugs for MDA 
is a growing concern to public health practices in endemic communities (Aksoy, 2010). 
The Global Partnership for the Eradication of NTD has reached more than700 million 
people with PCT drugs by the end of 2013 (WHO, 2013). However, this represents only 
35% of those in need of chemotherapy worldwide (WHO, 2013). Consequently, 
innovative approaches to policy and research are needed if the Millennium Development 
Goals (MDGs) for the eradication of “other diseases” is to be achieved (Spiegel et al., 
2010). So far, PCT coverage is the indicator for successful control of NTDs in affected 
countries (Hotez & Kamath, 2009) because of the substantial reduction in blood 
microfilaria population thereby lowering disease-specific morbidity and mortality 
(Simonsen et al., 2010a; Smits, 2009). Nonetheless, most developing countries continue 
to fall behind the WHO’s benchmarked target of >65% PCT coverage  because   
inadequate ecological structures impedes the  implementation of the MDA strategy 




MDA in endemic communities is necessary in order to develop systematic approaches 
towards elimination of tropical diseases in low- and middle-income economies.  
Supply chain research has  associated stronger logistics structures to a firm’s 
profitability, higher return-on-investment, and customer satisfaction (Green et al., 2008). 
Conversely, the association between supply chain capacity and disease prevention has 
received limited attention in public health research (de Vries, et al., 2011). Although 
there is evidence of association between supply chain capacity and improved health care 
(Lee et al., 2011), availability of essential medicines (Harding et  al., 2014) and  response 
to disease outbreak (Mbohwa, 2010), the effect of supply chain capacities on the 
availability of preventive chemotherapy drugs in the control of NTDs has not been 
explored.  
This exploratory study evaluated the association between supply chain capacity, 
measures by logistics performance indicators, and the control of NTDs, measured by 
MDA coverage of PCT drugs. The ecological model of health behavior (EMHB, Cohen 
et al., 2000) was the theoretical model used to explore the prediction of supply-chain 
capacity on MDA coverage of PCT drugs, to eliminate NTD in low- and middle-income 
tropical countries.  
Purpose of the Study 
The purpose of this study was to explore the quantitative association of supply 
chain capacity, and the control of tropical diseases, in tropical low- and middle-income 
endemic countries. The independent variable was supply chain capacity, which was 




(a) supply chain infrastructure (b) supply chain services (c) custom and border 
procedures, and (d) supply chain reliability (Arvis, Mustra, Ojala, Shepherd, & 
Saslavsky, 2014). The dependent variable was control of NTDs, which was measured by 
the annual MDA coverage of PCT drugs in endemic countries.  
The study was expected to contribute to filling gaps in the current epidemiological 
literature on alternative approaches to disease prevention  because it examined  consistent 
supply chain logistics management in low- and middle-income countries (Spiegel et al., 
2010). Furthermore, the study provided important evidence to support the need for supply 
chain infrastructure strengthening for the control of infectious tropical diseases and 
improved health outcomes in developing countries. 
Research Questions and Hypothesis 
RQ1: Is there a relationship between supply chain infrastructure and NTD control 
in low- and middle-income countries, as measured by MDA coverage of PCT 
drugs? 
H10: There is no significant relationship between supply chain infrastructure and 
NTD control in low- and middle-income countries, as measured by MDA 
coverage of PCT drugs. 
H1A: There is a significant relationship between supply chain infrastructure and 
NTD control in low- and middle-income countries, as measured by MDA 
coverage of PCT drugs. 
RQ2: Is there a relationship between logistics services and NTD control in low- 




H20: There is no significant relationship between logistics services, and 
NTD control in low- and middle-income countries, as measured by MDA 
coverage of PCT drugs. 
H2A: There is a significant relationship between logistics services, and 
NTD control in low and/or middle-income countries, as measured by MDA 
coverage of PCT drugs. 
RQ3: Is there a relationship between customs and border procedures, and NTD 
control in low- and middle-income countries, as measured by MDA coverage of 
PCT drugs?  
H30: There is no significant relationship between customs and border 
procedures, and NTD control in low- and middle-income countries, as measured 
by MDA coverage of PCT drugs.  
H3A: There is a significant relationship between customs and border 
procedures, and NTD control in low- and middle-income countries, as measured 
by MDA coverage of PCT drugs.  
RQ4: Is there a relationship between supply chain reliability, and NTD control in 
low- and middle-income countries, as measured by MDA coverage of PCT drugs?  
H40: There is no significant relationship between supply chain reliability, 
and NTD control in low- and middle-income countries, as measured by MDA 




H4A: There is a significant relationship between supply chain reliability, 
and NTD control in low- and middle-income countries, as measured by MDA 
coverage of PCT drugs.  
Theoretical Framework 
The Theoretical Framework upon which this study was based, is the “ecological 
model of health behavior”, determined by structural mechanisms by which population-
level factors effect change in individual health behaviors (Cohen, Scribner, & Farley, 
2000). This theory posits that structural factors at the population level are important in 
improving nations’ health. The model identified four categories of structural factors that 
affect health: (a) availability of consumer products (b) physical structures (c) social 
structures and policies and (d) cultural messages (Cohen et al., 2000). 
Building on existing ecological theories, Cohen’s model identified ecological-
level structures that influence behavior and affect individual health outcomes. These 
ecological structures influences individual’s constraining or mitigating health behaviors, 
access to health enhancing chemotherapy and control of infectious diseases (Cohen et al., 
2000). Nonetheless, supply chain ecological structures may constrain access to preventive 
care and improved wellbeing but it largely remains unexplored in epidemiological 
literature.   
Interventions for the elimination of NTD are aimed at addressing ecological 
factors that influence health. NTD disproportionally affect the poor and marginalized in 
society due to limited access to environmental conditions that promotes health (Addiss, 




population level transmission control through mass administration of preventive drugs, 
improving community level access to health infrastructure and promoting social equity. 
Therefore, exploring ecological structures that promote quality of health in the control of 
tropical diseases is needed. The use of the Ecological Structure Theory in this study was 
to test the hypothesis that structures at the national level influence the availability of 
preventive drugs that are used for mass administration of preventive drugs.  
Similarly, the Theoretical Framework for supply chain structure capacity was 
based on the ecological determinants of health using the logistics performance indicators. 
Ecological scores of logistics indicators are used to rank countries according to supply 
chain infrastructure, logistics services, customs and border procedure, and supply chain 
reliability to asses ease of trade facilitation and population wellbeing (Martí et al., 2014). 
Therefore, ecological evaluation of LPI relative to country’s capacity to control vector 
transmission will enhance public health’s understanding of disease prevention for 
improved health outcome.  
Nature of the Study 
This exploratory, quantitative, secondary data analysis explored relationships at 
the ecological level to determine the strength of supply chain logistics indicators in 
predicting MDA coverage of PCT drugs in the control of NTD. This is consistent with 
the theoretical framework of ecological structures in disease prevention and control. The 
independent construct were: (a) supply chain infrastructure (b) supply chain services (c) 
customs and border procedures, and (d) supply chain reliability (Arvis et al., 2014). 




their own country’s supply chain environments. The dependent variable was control of 
NTD, which was measured by annual MDA coverage for preventive chemotherapy and 
transmission drugs. 
The study used archival public data collected by the World Bank for the period 
2007, 2010, 2012 and 2014 as predictors (Arvis et al., 2007, 2014). Variations of 
predictors from 2007 to 2014 were analyzed for low- and middle-income endemic 
countries to evaluate improvements in each indicator over the period. Additionally, 
quantitative relationships between each predictor and MDA coverage of PCT drugs were 
explored using statistical regression analysis. 
Archival data from the World Health Organization’s (WHO) data repository for 
MDA population was analyzed. Annual MDA coverage of PCT for five tropical diseases 
are reported to WHO’s Global Health Observatory by endemic countries worldwide: (a) 
lymphatic filariasis, (b) soil-transmitted helminthic, (c) schistosomiasis, (d) 
onchocerciasis and (e) trachoma (WHO, 2013). MDA coverage was calculated as the 
ratio of population who have received preventive treatment doses of chemotherapeutic 
drugs, to those requiring preventive chemotherapy in the country (WHO, 2014). 
Coverage data from 2000 to 2014 for lymphatic filariasis was used in this study. The 
WHO’s benchmark of >65% MDA coverage of PCT drugs was used as the standard for 




Definitions of Terms and Variables 
     Terms 
Supply chain management: define as the integrated activities of planning, 
sourcing, procurement and logistics between suppliers, intermediary and customers 
(Council for Supply Chain Management Professionals, 2014). This term was used in this 
study to indicate the management of activities at population level that coordinate the 
distribution and storage of preventive chemotherapy drugs for mass administration in 
endemic countries.  
Logistics management:  part of supply chain management that plans, implements 
and control the efficient downstream distribution of products and services and upstream 
transmission of related information from the point of origin to the point of consumption 
(Council for Supply Chain Management Professionals, 2014). 
Healthcare supply chain or logistics management: this is the management, 
planning, implementation and efficient control of healthcare products and services from 
the manufacturer or service provider to the patients or population in need of the health 
products or services (de Vries, Huijsman, Meijboom, et al., 2011; Lega et al., 2012) 
NTD: a group of bacteria, virus, helminthes and parasitic diseases that affect and 
cause substantial illness in more than one billion people globally (WHO, 2013). In this 
study, NTD describes helminthic and other parasitic tropical diseases in which preventive 
chemotherapy and transmission control (PCT) are the control/elimination intervention. 
Mass drug administration (MDA): is the direct administration of preventive 




control, prevent and eliminate common or widespread disease irrespective of disease 
condition (WHO, 2013).  
Logistics performance index (LPI): interactive benchmark on indicators that 
identifies challenges and opportunities in trade logistics capacity across countries (Arvis 
et al., 2014). National LPI comprises four logistics indicators: supply chain infrastructure, 
logistics services, customs and boarder procures, and supply chain reliability (Arvis et al., 
2014).  
Low-income and middle- income countries (LMIC): the World Bank’s lending 
categorization of countries according to their gross national income (GNI) measured in 
2005 United States dollars per capita. In the fiscal year 2015, low-income countries are 
those with GNI per capita of $1,045 or less and middle-income countries are those with 
GNI per capita less than $12,746 but more than $1,045 (World Bank, 2014).  
Independent or predictor variables  
• Supply chain infrastructure: evaluates the quality of trade and transport 
infrastructure including road, rail, airport and information technology in 
the country. 
• Custom and border procedures: evaluates the efficiency of import/export 
clearance and transparency of customs and boarder agencies. 
• Supply chain services: evaluates the quality of transportation services 




• Supply chain reliability: evaluates sources of major delays in pre-shipment 
inspection, loss of products in transit, compulsory warehousing and 
solicitation of informal payment.  
Dependent or outcome variable 
The outcome variable was control of NTD defined by MDA coverage of PCT 
drugs. MDA coverage was calculated as the ratio of number of exposed people treated 
with preventive chemotherapy drug and the total population requiring preventive 
chemotherapy in the country. MDA coverage for the prevention of lymphatic filariasis 
was used as the dependent variable of interest. A successful MDA benchmark was 65% 
annual coverage per MDA event in the endemic country. 
Assumptions 
This study assumed that exploring the relationship between supply chain and 
disease prevention, using standardized tools, would reveal an association that could 
strengthen the supply chain in an effort to eliminate NTDs. It was also assumed that 
recommendations from this study might contribute to the field of supply chain 
epidemiology in exploring the role of supply chain structures in disease prevention in 
resource-limited economies.  
The use of secondary archival data in this research was based on the assumption 
that reliability and validity of the original data reflected respondents’ intention of supply 
performance in each country. Finally, the voluntary, annual MDA report to the WHO 
Global Disease Repository reflected the true coverage in each reported country and year.  




This study was limited to the application of supply chain logistics capacities to 
disease prevention in resource-limited settings. The role of the supply chain in tropical 
disease prevention was explored in this study due to the potential effect of logistics 
capacity on the distribution of essential chemotherapy drugs for the elimination of 
tropical infectious diseases. By linking supply chain capacity to the epidemiology of 
disease prevention, public health interventions for the sustainable elimination of tropical 
diseases can be enhanced. 
The population is defined as tropical diseases endemic to countries that have 
initiated mapping for preventive chemotherapy (WHO, 2013) eliminate lymphatic 
filariasis. Globally, there are about 1.2 billion people living in countries where preventive 
chemotherapy for tropical disease is required. Preventive treatment is required in 53 
tropical countries but only those countries with complete reported data between 2007 and 
2014  (41 countries) were used. Excluded in the study were countries that are outside the 
tropics, have a gross national income higher than $13,000 per capita, and have not 
initiated mapping for eliminating lymphatic filariasis. 
Limitations of the Study 
The study was limited to low- and middle-income economies where tropical 
disease is endemic. Another limitation of the study was the use of secondary archival data 
at the ecological level to measure independent and dependent constructs. This limited 
generalization of the study to developed countries and other low- and middle-income 




the study could be applied to other parasitic or viral diseases that are earmarked for 
elimination in infrastructural-limited developing countries. 
Significance of the Study 
The global fight to eliminate tropical diseases through MDA coverage of PCT 
drugs is under threat if factors affecting the distribution of preventive drugs are not 
explored (Krentel et al., 2013). This study explored the relationship between ecological 
structures and disease prevention in resource-limited, developing countries. With limited 
investments in disease prevention in developing countries, cost-effective alternatives to 
eradication of infectious diseases are needed in order to achieve MDGs (Parker & Allen, 
2011). Recommendations from this study are expected to contribute to social change by 
strengthening supply chain structures in low- and middle-income countries towards the 
elimination of tropical infectious diseases. As such, strengthened ecological structures are 
necessary for improved health outcomes in developing countries as determined by the 
ecological framework theory of this study (Cohen et al., 2000).  
Summary 
This chapter introduced the study, highlighted the problems addressed, theoretical 
framework used and the overarching purpose. The independent variables were based on 
ecological structures that determines supply chain capacity in trade and disease 
elimination. Measurement of structural capacity at the ecological level was introduced by 





Eradication of tropical diseases using mass administration of PCT drugs was to be 
achieved globally by 2020, with global pharmaceutical companies donating 
chemotherapy drugs to achieve these targets. However, inadequate ecological structures 
in most tropical disease endemic countries hampers attainment. Many factors may be 
attributable to this scenario but the current study explored quantitative prediction of 
supply chain capacity and control of tropical diseases with preventive chemotherapeutic 
drugs.  
Chapter 2 presents literature on the application of the ecological theory of disease 
prevention. Further, literature on the role of supply-chain capacity in business and 
economics will be explored for disease prevention. The chapter will end with criticism of 
existing literature on the subject of supply chain epidemiology and how this study could 
contribute to addressing these gaps.  
In chapter 3, methodologies of data collection, statistical analysis and hypothesis 
testing is presented, in addition to hypothesis testing. The chapter also explained the 
different predictors and outcomes, and how the use of bivariate and multivariate analysis 
model predicted relationship between variables. 
Chapter 4, presents the findings in tabular and graphs formats as well as 
interpretation of statistical significance of the result. Using linear regression analysis, it 
was predicted that each logistics performance indicator is linearly correlated to the 
coverage of MDA in the control of NTD in low-and middle-income countries. 
Individually, logistic infrastructure, customs and border processes, and supply chain 




Chapter 5 discussed the findings and their significance contribution to social 
change. The chapter also addressed research limitation, recommendations for further 
studies and a call for action by the global communities in strengthening supply chain 





Chapter 2: Literature Review 
Introduction 
NTD elimination with MDA of preventive chemotherapy drugs  is a growing 
concern to global public health research and practice in low- and middle-income endemic 
countries (Aksoy, 2010). The Global Partnership for the Elimination of NTD, a 
consortium of international public health practitioners, has treated more than700 million 
people with preventive chemotherapy drugs, but which is only 35% of those in need of 
treatment globally (WHO, 2014). As a result of the low coverage,  innovative policies 
and research are needed to increase treatment coverage in order to  achieve global 
elimination targeted by the year 2020 (Spiegel et al., 2010).  
Supply chain capacity has been associated with firm’s profitability, higher return 
on investment, and customer satisfaction (Green et al., 2008). Nonetheless, the 
application of supply-chain capacity in disease prevention interventions, especially for 
the distribution of preventive chemotherapy drugs in endemic communities, is largely 
unexplored (de Vries et al., 2011; Aksoy, 2010). This study explored the association 
between supply chain capacity, determined by LPI, and the control of NTD by MDA of 
PCT drugs in developing countries. 
Empirical review of the preventive literature revealed significant gaps in 
innovative theories on the role of supply chain in disease prevention intervention. 
Whereas research on the effectiveness of preventive chemotherapy for  NTD elimination 
has been explored (Hanson et al., 2012; Hotez, 2009; Parker & Allen, 2011), little is 




elimination. Consequently, research on the impact of supply-chain capacity in disease 
prevention using epidemiological theories is expected to contribute to the body of 
knowledge of supply chain epidemiology.  
This chapter reviews the relevant literature on the control of NTD using MDA of 
PCT in endemic countries relative to supply chain capacity in an effort to explore 
mitigating factors influencing tropical disease prevention in resource-limited settings. 
The chapter reviews relevant theories, discusses existing strategies of NTD control, 
supply chain capacity indicators, and the epidemiology of NTD to highlight existing 
literature gaps on supply-chain capacity in disease prevention.  
Literature Search Strategy 
The following databases were used for this review: Google Scholar, EBSCO, 
ProQuest, PubMed, Academic Search Premier, MEDLINE, CINAHL, Business Source 
Complete, ABI/INFORM Complete and SAGE Premier. The WHO Global Disease 
Observatory and the World Bank Open Knowledge Repository were also of particular 
use. To locate the relevant literature, these terms were searched: supply chain, logistics, 
supply chain management, neglected tropical diseases, public health supply chain, 
healthcare supply chain, mass drugs administration, logistics performance measure, 
logistics performance index, control of neglected diseases, supply chain theories, and 
low-and middle-come countries.  
Theoretical Foundation  
According to Berkman and Kawachi (2000), theoretical frameworks targeting 




Interventions focusing on intra- and inter-personal levels are within individual’s control, 
and those at the ecological level are external to personal control. Ecological interventions 
recognize the influence of environmental, social, and structural factors on health 
outcomes. Subsequently, manipulation of environmental, structure and social conditions 
in which people live can affect individual and population health, thereby reducing 
morbidity and mortality of infectious diseases.  
The theoretical framework, upon which this study was based, is the “ecological 
model of health behavior”, which determine structural mechanisms by which population-
level factors effect change in individual health behaviors (Cohen, 2000). This theory 
posits that structural factors at the population level are important in improving individual 
and community health outcomes. The theory identifies four categories of structural 
factors that affect health outcomes: (a) availability of essential health products (b) 
physical structures that influence behavior (c) social structures that limit high-risk and 
encourages low-risk behaviors, and (d) cultural messages that influence health (Cohen et 
al., 2000). 
Building on existing ecological theories, Cohen et al., (2000) identified ecological 
structures as safe roads, transportation and vector control, which are influencers of 
individual and population health status. Accordingly, ecological structural factors may 
mitigate access to health enhancing chemotherapy in the control of infectious diseases. 
However, ecological structures in low- and middle-income countries are inadequate, 




Conversely, other researchers have argued that neighborhood socio-economic 
conditions, rather than ecological factors, are important determinants of individual and 
population health (Wen, Browning & Cagney, 2003). These researchers suggested that 
conceptual model theory, which correlates neighborhood poverty and affluent to health 
outcome, determines population health. Accordingly, conceptual model theory of 
economic structures should be the basis of population-based interventions.  
Paradoxically, the conceptual model theory proposed by Wen et al., (2003) only 
explains differences in individual’s socio-economic status and not ecological structures 
that determine population health outcome. For this reason, adopting the conceptual model 
theory of health behavior in this study may not adequately explains ecological influencers 
of preventive chemotherapy in the elimination of infectious diseases. 
Even so, other researchers have adopted Cohen’s ecological framework to 
evaluate organizational decision latitude, modeled adolescence health behaviors and 
predicted regimen adherence; pointing to the strength of this theory in disease prevention 
(Elovainio, Kivimaki, Steen & Vahtera, 2004). In the control of tropical diseases, 
delivering preventive chemotherapy to endemic communities is critical to successful 
disease control. Therefore, the use of the ecological model of health behavior which 
determine structural mechanisms in which population-level factors effect change in 
individual health behaviors in this research, is justified. 
NTD  
     Infectious diseases are the leading cause of morbidity and mortality in 




(Engels & Savioli, 2006). NTD are a group of infectious diseases with two important 
shared characteristics; (a) predominates in the tropics and (b) largely neglected by 
governments, funders, researchers and policymakers (Feasey et al., 2010). Transmitted by 
vectors (protozoa, helminthes and bacteria), NTD affect bottom billion of the world’s 
poorest population causing extensive suffering, disfiguration, long-term disability, social 
neglect, loss of income and premature deaths (Hotez, Savioli, & Molyneux, 2009). NTD 
disproportionately affect low- and middle-income countries due to inadequate health, 
social and economic structures to support effective control strategies. Consequently, 
strong health infrastructure and strengthened population-level capacities can lead to 
elimination of NTD in developing countries. 
Epidemiology of NTD 
In recent years, the devastating impact of NTD has received public health 
attention through the WHO collaborative partnership program to eliminate tropical 
infectious diseases (WHO, 2014). Thirteen high-prevalence tropical diseases, causing 
substantial disabilities and mortality, are earmarked for elimination in 2020 by the WHO 
partnership. Seven of the thirteen are to be eliminated with MDA of PCT drugs (Table 1).  
Table 1 
Epidemiology of seven NTDs targeted for elimination by PCT 
Disease Causative 
agent 
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a. Adopted with permission from WHO (2013), Tropical Disease Repository website 
Together, the seven tropical diseases accounted for more than 13 million 
disabilities in life-years lost among one-fifth of the world’s population (Fenwick, 2012; 
Mathers, Ezzati, & Lopez, 2007). At the same time, most endemic countries suffer from 
multiple infections, hence requiring combination of preventive treatment packages.  
As depicted in Table 1, the highest burden of preventable NTD is lymphatic 
filariasis which accounts for nearly 6 million disabilities in 1.4 billion of the world’s 
poorest population. Subsequently, elimination of LF will have stronger public health 
impact in reducing social, economic and health burdens of NTD. Consequently, research 
into factors affecting the impact of, and subsequent elimination of LF will have 
significant social change contribution to endemic communities, donors, governments and 
policymakers. This research, therefore, focused on the ecological factors affecting the 
annual MDA coverage of PCT drugs distribution for the elimination of LF in developing 
countries. 
NTD Control 
Effort towards the elimination of NTD in endemic countries has received limited 
public health attention, until recently. The WHO’s Millennium agenda (WHO, 2006), the 
London Declaration and the Global Plan to Eradicate Neglected Tropical Disease, 2008 – 
2020 are among the global forum aimed at eradicating tropical diseases (WHO, 2007). 
The objectives of these programs were: (a) stop vector-transmission through the 
administration of PCT drugs; and (b) alleviate the suffering of affected populations 




The WHO guideline for NTDs elimination recommended MDA of PCT drugs, 
disease management, vector control, veterinary public health and provision of safe 
drinking water as five overarching interventions to eradicate NTD in endemic 
communities (WHO, 2006). So far, annual MDA  coverage of PCT drugs, is the driver of 
success of these interventions partly due to large donation of drugs by pharmaceutical 
companies, international donors and governments (Hotez & Kamath, 2009). Thus far, 
over 700 million doses of PCT drugs combination of diethylcarbamazine, ivemectin, and 
albendazole have been delivered to affected communities (WHO, 2014), but this 
represent 35% of population in need of PCT drugs. Additionally, NTDs are co-endemic 
(e.g. lymphatic filariasis and onchocerciasis), as such PCT drugs combinations provide 
protection for multiple diseases, further reducing the burden on endemic communities 
(Hanson et al., 2012). For instance, repeated MDA of PCT drugs combinations  in 
endemic communities was shown to substantially reduce the blood microfilariae levels 
from 24.5 to 2.7%, of felarial antigen from 53.3 to 19.6%, and antibodies to filarial 
antigen from 78.9 to 27.5% in the control of Lymphatic Filariasis in Tanzania (Simonsen 
et al., 2013). Hence, repeated administration of PCT drugs results in significant reduction 
in infections of tropical diseases. 
However, gap remains in endemic countries’ capacity to implement annual MDA 
of PCT drugs due to structure inefficiencies (WHO, 2014). Whiles large-scale donation 
of essential preventive medicines by pharmaceutical manufacturers and donors have 
improved availability, access to these medications in endemic communities is below 65% 




WHO, 2010). Reasons attributed to this trend include inadequate health infrastructure, 
limited resources to mobilize large-scale distribution of donated drugs, and ecological 
structures to sustain donor contributions (Krentel et al., 2013). Nevertheless, PCT drugs 
implementation remains the prioritized strategy to successfully eliminate NTD by 2020 
(WHO, 2010).  
On the other hand, some researchers have questioned the prioritization of PCT as 
the ultimate strategy for NTD elimination (Conteh, Engels, & Molyneux, 2010; Parker & 
Allen, 2011; Spiegel et al., 2010). Spiegel et al., (2010) argued against the 
“overmedication” of the population at the detriment of social determinants of health. 
Similarly, Conteh et al., (2010), argued on the “catastrophic” effect of NTD on household 
income, whiles Parker & Allen (2011) questioned the overall effectiveness of MDA as 
effective tool for tropical disease elimination. Even with these arguments, the overall 
benefit of PCT, which are: low cost-per-patients, population effect, and large reduction in 
disabilities annually (over 50 million in Table 1), makes it the preferred intervention 
strategy for eventual elimination (Fenwick, 2012). For this reason, the current research 
focused on annual MDA of PCT drugs as preferred intervention for global elimination of 
infectious tropical diseases in developing countries. This research, therefore, 
hypothesizes that ecological supply chain structures in developing countries is associated 
with the control of tropical diseases using the annual administration of PCT drugs in 




Constructs of Supply Chain Logistics Capacity  
The role of supply chain constructs in public health epidemiological research has 
received limited attention by researchers, governments and policymakers alike. Whereas 
supply chain theoretical principles are applied in private, business, manufacturing and 
retail services, its application to healthcare infrastructure, disease prevention, and 
elimination of preventable infectious diseases is still in infancy (Lee et al., 2011). Thus, a 
new research paradigm of supply chain epidemiology”, where supply chain principles are 
used to inform public health interventions, strategies and policies, is necessitated. This 
research leveraged lessons learned in supply chain principles from other disciplines to 
disease prevention.  
Diversity of Supply Chain Theoretical Principles 
Theories of supply chain are complicated because of multi-disciplinary nature of 
the subject matter. Hence, underpinning a single theoretical construct that delineate the 
overall efficiency of supply chain performance in one field of study may lead to 
inconsistence literature gap (Chen & Paulraj, 2004b). In a systematic review of over one-
hundred articles across several disciplines, Burgess et al., (2006) revealed inconsistencies 
in theoretical and methodological application of supply chain research in economic, 
business and healthcare (Burgess, Singh, & Koroglu, 2006). This inconsistency, further 
aggravated the need to streamline research constructs in understanding the influence of 
supply chain on disease prevention. Perhaps, this may be the reason why prevention 
research literature is limited in leveraging the experiences of the private sector systems to 




In a similar meta-analysis of more than 638 articles related to supply chain, 181 
different theoretical constructs were used to hypothesize the relationship between supply 
chain and outcome variables, further confirming the diversity of theoretical principles 
(Defee, Williams, Randall, & Thomas, 2010). All the same, with increasing globalization, 
coupled with non-barrier transmission of infectious diseases (e.g. Ebola, MERS, SARS 
etc.), there is the need for public health practitioners to learn from other research 
approaches.  
There has been significant return-on-investment, improved firm’s profitability, 
stronger competitiveness and client satisfaction, as a result of well-coordinated supply 
chain initiatives in developed countries. Nevertheless, this has not been applied in the 
public sector, particularly in the area of epidemiology for the control of infectious 
diseases in developing countries (Chen & Paulraj, 2004). For the field of Supply Chain 
Epidemiology to develop, theoretical principles in relation to ecological conditions that 
influence health, should be used to explore association between supply chain structures 
and disease prevention. Hence, this research leveraged on the ecological principles of 
health behavior to examine the association between supply chain capacity and control of 
infectious diseases in low-and middle-income countries.  
The ecological model of health behavior theory posits that, structural factors at 
the population level are important to improving nation’s health (Cohen et al., 2000). The 
model identifies four categories of structural factors: (a) availability of essential supplies, 
(b) physical capacity to distribute supplies to end-users (c) socio-economic structures and 




the current research employs structure constructs that measures supply chain efficiencies 
across nations and its relations to infectious disease elimination. Using the Logistics 
Performance Index (LPI), which is a measure of country’s logistics capabilities, supply 
chain structures in low- and middle-income countries was assessed relative to the control 
of infectious tropical diseases. 
Supply Chain Performance Evaluation 
Evaluating the efficiency of supply chain logistics activities was the subject of 
business and economic research in the early 1990s. As mentioned earlier, the complexity 
of supply chain processes make it difficult for a single quantitative model of 
measurement. Attempt by Beamon (1999), revealed variations in evaluation criteria for 
qualitative and quantitative studies of supply chain (Beamon, 1999). As a result, supply 
chain efficiencies were measured by categorization of services into quality, timely, 
flexibility, reliability, and cost (Beamon, 1999). The author bemoaned the weaknesses in 
this type of measurement and, consequently proposed three measures; resources, output 
and flexibility, which were to be linked with strategic goals (Beamon, 1999). With 
Beamon’s proposal, supply chain effectiveness were then measured with an index of 
return-on-investment, order fulfilment, customer satisfaction, product quality and demand 
variation (Beamon, 1999).  
Expanding on Beamon (1999) strategic framework, Gunasekaran et al., (2001) 
asserted that supply chain performance measurement must represent a “balanced” with 
strategic, tactical, and operational levels of management to accommodate third-party 




chain performance by incorporating partnership, and coordination of financial and non-
financial matrices (Gunasekran et al., 2001). Accordingly, it became imperative for 
organizations to utilize their supply chain capabilities, outsourced non-value added 
activities, and manage relationships to effectively bring products and services to end-
users. 
In comparing Beamon’s strategic resource matrix with Gunasekran’s balanced 
framework, both recognized the diversity of supply chain processes, aligning to strategic 
goal and interrelationship of matrices for supply chain efficiencies. In contrast, however, 
both works failed to incorporate environmental factors outside the organizations’ 
business processes, which may be paralleled to socio-structural determinants of health in 
epidemiology.  
Then, the “green supply chain” model, which depicted interaction of different 
organizations, processes and professionals in respond to firm’s internal and external 
collaborations (Hervani, Helms, & Sarkis, 2005). This model has, as its principle, 
ecological structural alignment with operational and strategic practices in order to 
achieve clients’ satisfaction (Hervani et al., 2005). Thereby recognizing internal capacity 
and ecological structural interface as interlocking mechanism of assessing performance 
(Hervani et al., 2005). This framework bears resemblance with the ecological structures 
of health behavior, which recognizes intra-personal, inter-personal and environmental 
factors that influence health outcome. Nonetheless, this resemblance has not been 
recognized by public health researchers, creating gaps in existing literature on the 




However, using single firm’s supply chain matrix to relate population-level health 
outcomes may be inappropriate to measure national health status. For that matter, a 
national-level performance indicator is prerequisite to quantifying ecological structures 
that influence community health outcome. With that in mind, the LPI, is an excellent 
national-level indicator that evaluates countries’ supply chain capacities in relation to 
trade, policy and potentially health outcome (Arvis et al., 2007). 
Logistics Performance Index (LPI) 
 The LPI is a multidimensional assessment tool for measuring efficiency and 
reliability of supply chain structures in national and international trade capacities (Arvis 
et al., 2007). Developed by the World Bank, academics and logistics service providers, 
the LPI surveys logistics professionals, small and medium size freight forwarders, and 
global express carriers working in their own countries, to identify challenges and 
opportunities of trade efficiencies (Arvis et al., 2007). Since 2007, the LPI has been used 
to evaluate supply chain efficiencies of more than150 countries surveying over 1000 
professionals in the countries they operate (Arvis et al., 2007). The LPI is structured 
along international and domestic capacities using quantitative benchmark to rank 
“logistics friendliness” of participating countries (Arvis, Mustra, Ojala, Shepherd, & 
Saslavsky, 2010).  
 The six international dimensions of LPI are: (a) customs processes, (b) logistics 
infrastructure, (c) international shipment, (d) quality of logistics services, (e) tracking and 
tracing and (f) timeliness (Arvis et al., 2010). Scores from each dimension are averaged 




low score of 1 determines the level of infrastructure development, investments 
opportunities and diversification. (Arvis, Mustra, Ojala, Shepherd, & Saslavsky, 2012).  
The four domestic dimensions of LPI, which looks at the logistics environment 
within national boundaries are: (a) logistics infrastructure, (b) quality of logistics 
services, (c) customs and border procedures and (d) supply chain reliability (Arvis et al., 
2012). Again, each dimension is scored and aggregated to rank domestic supply chain 
reliability, economic growth and poverty in developing countries (Arvis et al., 2014). 
Table 2 demonstrates the interconnectedness of the two dimensions of LPI. 
Table 2  
International and domestic dimensions of LPI  
LPI International Domestic Related to 
Customs process yes yes border procedures  
Logistics 
infrastructure 
yes yes infrastructure 
International shipment yes no  
Quality of logistics 
services 
yes yes services 
Tracking and tracing yes yes supply chain 
reliability 
Timeliness yes no  
 
Customs and border procedures (CUS). Measures the efficiency of border 
clearing agencies and processes including custom services (Arvis et al., 2007). This 
indicator is the same for international and domestic level measurements as it relates to 
border and custom processes within national boundaries.  
Logistics infrastructure (INF). Measures the quality of telecommunication, 




Infrastructure efficiencies determine the constraints or improvements in logistics 
activities resulting from road network, air and sea capacities in a country. 
Quality of logistics services (SER). Measures the quality of, and competency of 
logistics services providers in the country (Arvis et al., 2012). It relates to the availability 
of freight forwarders, transport service providers and other private and public agencies 
that facilitates the movements of goods and services in a country.  
Supply chain reliability (REL). Similar to track and tracing, the supply chain 
reliability measures the speed at which a specific product reached the end-user (Arvis et 
al., 2014). At the same time, it relates to the efficiencies of tracking a product once it is in 
the country; in case of products recall, damages, loss in transit and traceability (Arvis et 
al., 2014).  
Unlike other supply chain measurements indices (Beamon, 1999; Gunasekaran, 
Patel, & Tirtiroglu, 2001; Hervani et al., 2005), the LPI defines national structures that 
influence trade, socioeconomic conditions and health determinants (Arvis et al., 2007, 
2010, 2012, 2014). For this reason, application of LPI in epidemiological research may 
provide significant socioeconomic measures that may influence health behaviors. It is the 
hope of this researcher that by estimating the impact of these supply chain structures, 
opportunities may exist for improvement in order to eradicate poverty, better health 
conditions and eliminate infectious diseases.  
LPI and Socioeconomic Conditions in Low- and middle-income Countries 
The World Bank and other development partners have used the LPI to assess 




LPI survey in 2007 highlighted supply chain gaps in developing economies, which 
hinders their competitiveness in the global market (Arvis et al., 2007). Observed 
structural differences between developed and developing countries therefore highlighted 
the role of logistics indicators to economic growth. Consequently, the LPI became a 
benchmark for economic reforms in developing economies by identifying structural 
challenges and opportunities to improved national outcomes (Arvis et al., 2007). For 
instance, Singapore, Netherlands and Germany were the top three performers in 2007 
whereas Rwanda, Timor-Leste and Afghanistan were the bottom performers, further 
highlighting the relationship between logistics performance and economic development 
(Arvis et al., 2007).  
In the 2010 survey, LPI depicted the significant of efficient logistics performance 
to product diversity, direct development and economic growth (Arvis et al., 2010). More 
so, logistics performance was related to supply chain reliability, and predictability. 
Additionally, the level of logistics services available in higher performing countries more 
than doubles that of low performing countries (Arvis et al., 2010). Furthermore, the 
difference in LPI scores between low-performing and high-performing countries reflected 
the economic gaps in infrastructure developments. Therefore, developing countries were 
disadvantaged in providing health-enhancing environment for their population well-being 
as a result of low logistics performance (Arvis et al., 2010). 
Other LPI surveys of 2012 (Arvis, et al., 2012) and 2014 (Arvis et al., 2014) 
supported the role of logistics performance in developing countries’ structural and 




lowest performers respectively, whereas Germany and Somalia were the top and lowest 
performers for 2014. Consistently, developed countries with advanced structures have 
high ranking, whiles those with limited infrastructure are at the bottom. LPI rankings, 
therefore, represent the level of economic conditions that may relate to health-enhancing 
infrastructure. Subsequently, this research hypothesized that estimating logistics 
structures in developing countries provide evidence of strength or weaknesses of health-
enhancing structures that may impact infectious disease elimination.  
Other researchers have highlighted the relationship between LPI scores and social 
conditions (Gunner & Cookson, 2012). Using LPI scores, Gunner & Cookson (2012) 
performed regression analysis and found that social predictors relates to logistics 
performance similar to economic indicators (Guner & Coskun, 2012). Social predictors 
were risky behaviors, democracy, and human development, which are ecological 
determinants of socio-economic wellbeing of a country. Thus, the work of Guner & 
Coskun (2012) expanded on the application of LPI, beyond economic indicators, to social 
conditions that may influence health. Because of the interlocking relationship between 
social conditions and population health (Beckman & Kawachi, 2000), estimating LPI 
scores for developing countries may revealed social and structural conditions that 
mitigate the control of tropical diseases.  
Notwithstanding Guner & Coskun’ (2012) work, other researchers have used the 
LPI to analyze socioeconomic strengths of emerging economies (Marti, Puertas, & 
García, 2014). Using the gravity equation, the impact of logistics structures on emerging 




infrastructure in developing countries are related to their supply chain logistics capacity 
(Marti et al., 2014). Implying that emerging economies are exposed to varying logistics 
and supply chain challenges which may influence their trade competitiveness, poverty 
alleviation and wellbeing (Mart et al., 2014).  
In summary, empirical studies have shown that logistics and supply chain 
contribute to country’s socioeconomic conditions. Specifically, LPI has become a 
benchmark for comparing global logistics infrastructure across countries (Martí et al., 
2014). At the same time, there is growing evidence associating socioeconomic conditions 
and health outcome (Adler & Rehkopf, 2008; Allotey, Reidpath, & Pokhrel, 2010; S. 
Cohen, 2004), further suggesting the possible association of supply chain logistics to 
disease prevention. In light of this evidence, I explored the association between logistics 
indicators and the control of infectious tropical diseases in low- and middle-income 
countries. 
Supply Chain Capacity and Disease Prevention      
Limited empirical research is available which relates supply chain to health 
service delivery, particularly for tropical infectious diseases prevention. In an earlier 
attempt, Samuel et al., (2010) alluded to the dynamics of health systems due to multiple 
stages of service-oriented supply chain (Samuel, Gonapa, Chaudhary, & Mishra, 2010). 
Using the bullwhip effect, the authors developed multistage model for hospital operations 
revealing that patients’ experience is improved when stages are reduced (Samuel et al., 
2010). However, this model did not address the interconnectedness of other players 




considered other players in the logistic industry, it could have revealed the dynamics of 
supply chain in the health sector. 
Perhaps, a more comprehensive review of healthcare supply chain was the work 
of de Vries and Huijsman (2011), which draws parallel between industrial supply chain 
and the health services industry (de Vries, Huijsman, de Vries, et al., 2011). According to 
these authors, core to supply chain principles in health sector are performance 
improvements, waste reduction, coordination of processes, building relationships, 
collaboration, and patients care (de Vries, Huijsman, de Vries, et al., 2011).  
Unlike supply chain in the industrial sector, which moves goods and services, that 
of health care industry goes beyond the movement of physical goods (pharmaceutical and 
medical devices), to include patients and information flow. Thereby making the 
healthcare sector supply chain unique compared to other sectors; as a result the health 
sector lags behind the industrial sector in measuring the impact of supply chain capacity 
to health interventions. Even with its uniqueness, concepts, models and practices of 
industrial sector supply chain may benefit health sector’s transformation (de Vries et al., 
2011). Thus, lessons learned from other disciplines should underpin research assumptions 
of supply chain in disease prevention. In light of this, I used lessons learned from 
industrial sector to explore the relationship between supply chain capacity and control of 
tropical diseases in low- and middle-income countries. 
Learning from previous healthcare research, supply chain innovation was found to 
correlate with hospital performance and patients care (Lee et al., 2011). Similarly, supply 




inventories (Nagurney, Masoumi, & Yu, 2012), vaccines (Haidari et al., 2013), essential 
medicines (Chandani et al., 2012), and disease outbreaks (Mbohwa, 2010). In responding 
to disease outbreak (e.g. cholera, Tsunami, Hurricane and Ebola), insufficient logistics 
infrastructure, including customs delays, poor road network and inadequate information 
and communication technology, delayed response time resulting in loss of lives and 
properties (Mbohwa, 2010). 
Supply chain optimization model was used to develop cost-effective logistics 
systems for the distribution of human blood leading to improved availability of life-
saving perishable inventory (Nagurney et al., 2012). Similarly, supply chain 
infrastructure capacity reduced the availability of critical maternal-and-child care 
commodities, thereby increasing childhood mortalities in low- and middle-income 
countries (Chandani et al., 2012). In both studies, community-level stock out of 
“indicator products”— blood product and oral rehydration salt, was used to evaluate the 
relationship of supply chain and health systems.  
Using the highly extensible resource for modeling supply chain (HERMS) 
software, Haidari et al., (2013) modeled the efficient mix of transport and storage that 
resulted in more than 30% increase in vaccines availability in developing countries which 
reduced vaccine-preventable diseases mortalities in resource-limited countries (Haidari et 
al., 2014).  
Interestingly, the application of supply chain principles to health care research 
resulted in fragmented theories and multiple measurement matrices. Clearly, existing 




attention to public health interventions. Hence, the existing gaps in the field of supply 
chain epidemiology can be addressed if public health intervention research employs 
epidemiological theories, and uses standard matrix to evaluate the impact of supply chain 
capacity to disease prevention. Particularly, exploring the effect of supply chain in low- 
and middle-income countries may allow policymakers and public health practitioners to 
strengthen ecological structure towards NTD elimination by the target year of 2020. 
Summary and Conclusions 
This chapter reviewed literature in the area of supply chain epidemiology. 
Specifically, the outcome variable, which is control of NTDs, was discussed in relation to 
mass administration of preventive chemotherapy and transmission drugs used for the 
elimination of infectious tropical diseases. The efficiency of MDA for the control of NTD 
was demonstrated using relevant literature. Implying that successive annual MDA of PCT 
drugs may lead to the control of multiple tropical diseases in low- and middle-income 
countries. 
Additionally, the independent variables were discussed in relation to LPI, which 
is a standard matrix of indicators for measuring supply chain capacity in multiple 
countries. Developed by the World Bank, in collaboration with stakeholders and 
academia, the LPI has been used by other researchers to compare economic and social 
structures across nations. Categorized as domestic and international, four variables 
measure performance within national boundaries (domestics) and six variables measure 
performance between boundaries (international); relating it to public health intervention 




Literature on supply chain research is multidisciplinary and fragmented, making it 
difficult to relate a single epidemiological construct to logistics performance. Whereas 
supply chain research is matured in industrial and economic field, gap still remains in 
public health supply chain literature. Even though hospital supply chain was found to 
relate to patients’ care, there is limited application of the same principle to the control of 
NTD. Learning from the positive role of supply chain in industrial performance, there is 
the need for a paradigm shift in defining supply chain epidemiology using the concepts, 
theories and models of disease prevention. 
This study contributes to the body of knowledge in defining ecological supply 
chain structures to disease prevention. Importantly, using ecological theory of disease 
prevention, which is rooted in epidemiology, supply chain capacity in developing 
countries can be used predict control of NTD in order to reduce disability-adjusted life 
years, morbidity and mortalities associated with these diseases. 
In Chapter 3, research methodology and the relations between the dependent and 






Chapter 3: Research Method 
Introduction  
Control of NTD, with mass administration of preventive chemotherapy and 
transmission drugs, relative to supply chain logistics capacity, remains a challenge in 
resource-limited endemic countries. There are likely many reasons for this; however, this 
area of study has received limited attention by public health professionals, particularly in 
the area of epidemiology of tropical diseases prevention (Burgess, et al., 2006).  
This chapter presents research questions and hypotheses that forms the basis of 
this study. Methodology, data types, reliability, validity, statistical analysis and 
significance for predicting the association between supply chain capacity indicators and 
disease control are discussed.  
Research Design and Rationale 
This study used quantitative, secondary data analysis to predict relations between 
supply chain capacity and the control of neglected diseases in tropical countries. 
Quantitative correlational analysis at the ecological level of supply chain logistics 
capacity was evaluated using the following logistics indicators: supply chain 
infrastructure (H1), logistics services (H2), customs and border procedures (H3), and 
supply chain reliability (H4). This was consistent with the theoretical framework of 
ecological structures in disease prevention and control. Criterion construct was NTD 
control, measured by annual MDA of PCT drugs. The predictor variables include (H1) 
supply chain infrastructure, (H2) logistics services, (H3) customs and border procedures, 




al., 2014); a survey of logistics professionals who assess their own country’s logistics 
environments.  
Research Hypothesis and Questions 
The following research questions were used to explore relationships between 
criteria and predictor variables: 
RQ1: Is there a relationship between supply chain infrastructure and NTD control in low- 
and middle-income countries, as measured by MDA coverage of PCT drugs? 
H10: There is no significant relationship between supply chain 
infrastructure and NTD control in low- and middle-income countries, as measured 
by MDA coverage of PCT drugs. 
H1A: There is a significant relationship between supply chain 
infrastructure and NTD control in low- and middle-income countries, as measured 
by MDA coverage of PCT drugs. 
RQ2: Is there a relationship between logistics services and NTD control in low- 
and middle-income countries, as measured by MDA coverage of PCT drugs?  
H20: There is no significant relationship between logistics services, and 
NTD control in low- and middle-income countries, as measured by MDA 
coverage of PCT drugs. 
H2A: There is a significant relationship between logistics services, and 
NTD control in low and/or middle-income countries, as measured by MDA 




RQ3: Is there a relationship between customs and border procedures, and NTD control in 
low- and middle-income countries, as measured by MDA coverage of PCT drugs?  
H30: There is no significant relationship between customs and border 
procedures, and NTD control in low- and middle-income countries, as measured 
by MDA coverage of PCT drugs.  
H3A: There is a significant relationship between customs and border 
procedures, and NTD control in low- and middle-income countries, as measured 
by MDA coverage of PCT drugs.  
RQ4: Is there a relationship between supply chain reliability, and NTD control in low- 
and middle-income countries, as measured by MDA coverage of PCT drugs?  
H40: There is no significant relationship between supply chain reliability, and 
NTD control in low- and middle-income countries, as measured by MDA coverage of 
PCT drugs.  
H4A: There is a significant relationship between supply chain reliability, and NTD 






 Table 3 displays variables and statistical tests by hypothesis. The dependent 
variable in all four hypotheses is annual mass administration coverage of preventive 
chemotherapy drugs used to control transmission of NTDs, and the predictor variables 
are; supply chain infrastructure, logistics services, customs and border procedures, and 
supply chain reliability. 
Table 3.  







H1 Mass Drug Administration (MDA) of 
Preventive Chemotherapy (PCT) for the 






H2 Mass Drug Administration (MDA) of 
Preventive Chemotherapy (PCT) for the 





H3 Mass Drug Administration (MDA) of 
Preventive Chemotherapy (PCT) for the 






H4 Mass Drug Administration (MDA) of 
Preventive Chemotherapy (PCT) for the 








Population was defined in this study for the criterion variable is tropical countries 
that are endemic with one or more tropical diseases that have either or not initiated 
mapping for preventive chemotherapy and transmission control and reported at least two 




73 countries where preventive chemotherapy for tropical disease is required. Excluded 
from this population are countries that are outside the tropics, have gross national income 
higher than $13,000 per capita, and are not endemic for one or more NTDs. 
On the other hand, population for the indicator variables is 150 countries that have 
participated in at least one of the World Bank’s logistics capacity survey in 2007, 2010, 
2012 and 2014 survey periods. Excluded in this population are countries that have not 
participated in any of the World Bank’s survey periods. 
Sampling and Sampling Procedures  
A stratified random sample of 150 countries that participated in the LPI survey 
was used as sampling technique. Stratification will have allowed specific characteristics 
of individuals in a population to be reflected in the sampled stratum based on their true 
proportion in the population (Treiman, 2014). With this proposal, a minimum sample size 
required was 85 countries; that is, based on a formal power analysis shown in Table 4 
using G*Power. A medium effect size of .15 and an alpha (α) error probability of .05 
were estimated. Power was set at .80, meaning that an 80% chance of finding a 
relationship between variables with a less than a 5% chance of error if a true relationship 
exists in the population is expected.  
 
Table 4.  
A priori computed sample size - Linear multiple regression: Fixed model, R2 deviation 
from zero 
 
Analysis: Power Parameters Coefficient 
Input: Effect size f² 0.15 
 





Power (1-β error probability) 0.80 
 
Number of predictors 4 
Output: Non-centrality parameter λ 12.75 
 
Critical F 2.49 
 
Numerator degrees of freedom 4 
 
Denominator degrees of freedom 80 
 
Total sample size 85 
 Actual power 0.80 
 
However, not all the 150 countries are classified as low and middle income 
countries with tropical disease burden. Hence stratifying the population was necessitated 
to achieve inclusion criteria of the defined population. After stratification, 73 countries 
satisfied the inclusion criteria for tropical disease endemic low- and middle-income 
countries as well as participated in at least one LPI survey period. Out of the 73 countries, 
58 have not achieved eradication between 2007 and 2013. Hence these countries were 
regionally stratified and matched with their respective LPI survey period.  
Having matched the predictor and the criterion variables by region and country, 
only 41 have complete scores for each of the supply chain indicators across the survey 
period as well as reported MDA coverage information corresponding to the LPI. 
Subsequently only 41 related pairs (Pallant, 2013) were used for analysis. This 
corresponds to purposeful sampling technics resulting in 164 cases (41*4) that is 
statistically reliable for SPSS analysis with four variables (Pallant, 2013). For a 
statistically significant analysis in SPSS, minimum number of cases is: N > 50 + 8m 
(where m = number of variables and N = number of cases). Hence, the  minimal number 
of cases for the four independent variables (infrastructure, custom, services and 




Participation and Procedures for Recruitment  
Participants in this study for criterion variable are people living in tropical 
countries that are exposed to NTDs. The success of preventive chemotherapy in 
controlling NTD depends on annual coverage of MDA in endemic communities. MDA 
coverage is measured as the ratio of the population treated with preventive chemotherapy 
drugs relative to the exposed population in need of PCT drugs in each country annually 
(WHO, 2014).  
Likewise, participants for the predictor variables are supply chain professionals 
operating in their own countries with logistics responsibilities for the distribution of 
essential commodities across the country (World Bank, 2014). LPI is an online survey 
questionnaire that quantitatively evaluates the efficiency of custom processes, structural 
capacities, reliability and logistics services in each country (Arvis et al., 2007; 2014). The 
index combines an in-depth knowledge of logistics operators’ understanding of country 
context, and global logistics environment and supplemented with quantitative data of 
trade performance in each country. 
LMICs are categories of countries with annual Gross National Index (GNI) below 
US $13,000 measure per 2013-dollar value. LMIC are homes to more than 5 of the 7 
billion-world populations accounting for 73% of the world’s poor.  






The World Bank’s logistics indicators were used in this study. Started in 2007, the 
World Bank used the LPI to survey over 1000 professionals and agencies across 150 
countries involved in the different sectors of supply chain core activities in each country 
(Marti, et al., 2011). Respondents to the survey were asked to assess their country’s 
performance in national and international trade facilitation consisting of custom 
processes, logistics services, infrastructure, tracking and tracing and timeliness. Each 
indicator was rated 1 through 5 with 5 being the highest and 1 the lowest (A sample of 
2014 LPI questionnaire is provided in the Appendix).  
MDA coverage, on the other hand, is the of number of people treated with at least 
one dose of PCT drugs, divided by the estimated number of people in exposed 
communities requiring PCT for one or more tropical diseases in the country (WHO, 
2014). As part of the global effort to eliminate tropical diseases in endemic communities, 
the Tropical Disease Control Program in each endemic country initiates mapping of PCT 
as a strategy towards NTD elimination. Each PCT-initiated country voluntarily reports 
annual MDA coverage to the Global Health Observatory database for surveillance and 
monitoring progress towards global elimination. Successful annual coverage is 
benchmarked at >65% coverage of population requiring PCT, and six successful annual 




Data Collection Technique 
This study used archival data collected by international public agencies for both 
the criterion and the predictor variables. The World Bank’s data repository of LPIs for 
150 countries was extracted for 2007, 2010, 2012 and 2014 survey periods as predictors. 
At the same time, data from the WHO Global Disease Registry (GDR) for annual MDA 
of PCT drugs for lymphatic filariasis was extracted for criterion variable. 
Data Organization Techniques 
Extracted data was systematically organized electronically and in hard copies. 
Electronic data organization techniques used are; Dropbox, Google Drive, Zotero, Excel 
files and folders. Folders were created for each type of data according to subject index, 
by country, and by predictor variable. At the same time hard copies of each dataset 
printed and kept in files for ease of reference and traceability. Other techniques of data 
organization were Historical Alignment Tool (HAT), journal logs, bibliography, and 
index cards. Collected data were secured in different formats electronically and hard 
copies and will remain so for at least 5years after the approved final dissertation. Data 
disposition shall follow Walden University’s data disposition guidelines. 
 Data Analysis Technique 
 
Statistical Tests 
To test the research hypotheses, a multiple regression model was designed. The 
model was constructed to explore statistical relationship between the control of NTD, 




infrastructure (H1), logistics services (H2), customs and border procedures (H3), and 
supply chain reliability (H4). This model was used to test the four hypotheses for this 
study and labeled after the dependent variable, control of tropical diseases. The construct 
of the model was:   
Control of NTD (Y) = β0 + β1Infrastructure(X1) +  β2Services(X2) + β3Border 
and time (X3) + β4Supply chair reliability(X4) + €. 
 
The predictor variables are signified with X, and Y represents the dependent 
variable. The regression coefficients, βn, for the models are the variance of scores 
attributed to each predictor variable relative to the outcome variable. The symbol € 
represents an error term generally distributed around a mean of zero. 
Threats to Validity  
Reliability 
Reliability of survey instruments measure internal consistencies of scores, 
stability and administration over time (Creswell, 2013). The LPI have been used since its 
development in 2007 to collect data from more 1000 professionals across multiple 
countries and was found to consistently give repeatable result over the collection periods 
(Martí, Puertas, & García, 2014b). Outcome of the survey using LPI was used to compare 
logistics performance and trade facilitations in more than 140 countries in 2007, 2010, 
2012 and 2014 which consistently ranked logistics performance in participating nations 





Validity in quantitative research refers to whether meaningful conclusions can be 
drawn from scores of a particular instrument (Creswell, 2013). Researchers in business 
and administration have used the outcome of LPI surveys to guide policymakers in 
creating sustainable structures, improved transportation and facilitated trade comparisons 
among nations (Charkaoui, Ouahman, & Bouayyad, 2012). In developing the LPIs, 
professionals, academia and representatives of professional freight forwarding agencies 
rated the constructs in the index, which was statistically validated by the World Bank. 
According to the World Bank, the indicators of LPI were statistically validated using 
principal component analysis (PCA), a statistical technique used to reduce dimensionality 
of datasets, the Kaiser Criterion and the Eigenvalue scree plots (Arvis et al., 2014).  
Ethical Procedures 
Data employed in this study is historical archive, which is publicly available to 
researchers and other users. In addition, the data is aggregated at national level without 
revealing individual’s personal information. Aggregated by country, the outcome variable 
is measured as a percentage of number of people treated with one or more chemotherapy 
drugs, irrespective of health status, over estimated number of people in need of 
preventive chemotherapy. There is no indication of specific individual’s health status or 
personal information that may compromise individual’s right. The predictor variable, is 
an anonymous survey of freight forwarding professionals, and does not collect 
individual’s health or personal information. Nonetheless, permission was requested from 




Appendix). Also, Walden University’s Institutional Review Board (IRB)’s approval was 
requested prior to collection and analysis of data. 
Summary 
This chapter highlighted the methodology used in this study. Specifically, 
definitions of participants, sample type, size, research questions, research hypotheses and 
statistical analysis used in the study were discussed. Data management techniques, 
validity and reliabilities of the survey instruments were given in this chapter. Datasets for 
the different constructs of the predictor and outcome variables of this study were 
similarly defined. In Chapter 4, the results of the study are displayed in tabular and 






Chapter 4: Results  
Introduction 
The purpose of this study was to explore the association between supply chain 
logistics capacity and the control of infectious NTDs in low- and middle-income 
countries. Specifically, the research explored answers to the following questions:  
• Is there a relationship between supply chain infrastructure and NTD 
control in low- and middle-income countries, as measured by MDA 
coverage of PCT drugs? 
• Is there a relationship between logistics services and NTD control in low- 
and middle-income countries, as measured by MDA coverage of PCT 
drugs?  
• Is there a relationship between customs and border procedures, and NTD 
control in low- and middle-income countries, as measured by MDA 
coverage of PCT drugs?  
• Is there a relationship between supply chain reliability, and NTD control 
in low- and middle-income countries, as measured by MDA coverage of 
PCT drugs?  
Secondary archival data was collected, reviewed and statistically analyzed to 
explore relationships between each of the four predictor variable and the outcome 
variable. This chapter highlights the results of statistical analysis  (univariate, bivariate, 
and multiple linear regression) and hypothesis testing (answers to research questions) in 




Data Collection and Validation 
Archived secondary data was extracted between April and July 2015 from the 
WHO and the World Bank open access data libraries respectively, after obtaining 
permission from both agencies. The predictor variables, logistics performance index, 
were extracted for the survey periods 2007, 2010, 2012 and 2014 for all the 150 
participating countries (World Bank, 2014). The criterion variable, annual MDA 
metadata, were extracted for the period 2000 through 2013 for lymphatic filariasis 
endemic countries (WHO, 2014). Because of observed differences in reporting periods 
(2000 to 2013 for criterion and 2007 to 2014 for predictors), and the variations in 
participating countries (150 for predictors, and 73 for criterion), direct sample 
stratification of related pairs, which is required for statistical analysis was not feasible. 
Related pairs are matched subjects (or countries) such that scores on each dependent and 
independent variables are matched or related for the same sampling period (Pallant, 
2013). Because of this difficulty, purposeful matching pairs, using the baseline of LPI 
survey years, was used to compare predictor and criterion variables (Table 5). 
Consequently, LPI scores of participating low-and middle-income countries, stratified by 
regions, were purposefully matched for analysis. The reason for matching three 
consecutive years of MDA coverage to one LPI survey year is because of empirical 
evidence that tropical disease prevalence remains unchanged over a short range of period, 
as such, data from close years are approximated (Ramaiah & Ottesen, 2014).  
Table 5. 
 





In contrast to the direct stratified sample 
technique proposed in Chapter 3, purposeful 
stratified mapping of related pairs  was used to map 
the independent with the dependent variables 
(Green & Salkind, 2011; Pallant, 2013). Whereas 
the scores for the 150 countries participated in the LPI surveys were available, 73 
countries are classified as low-and middle-income countries. Of the 73 LMIC, 53 have 
initiated at least two years of MDA coverage mapping for lymphatic filariasis preventive 
chemotherapy; an inclusion criteria for this study (see Chapter 3). Therefore, related pairs 
mapped LPI scores with MDA coverage of PCT drugs yielded 41 countries for each 
participating years of 2007, 2010, 2012 and 2014, resulting to 164 (41*4) related cases. 
For a statistically significant analysis in SPSS, minimum number of cases is: N > 50 + 
8m (where m = number of variables and N = number of cases). Hence, the  minimal 
number of cases for the four independent variables (infrastructure, custom, services and 
reliability) is 82 (Tabachnick & Fidell, 2013, p.123).  
Missing Data 
 Missing data may influence the output of statistical analysis. Therefore, 
investigating missing data and adjusting thereof, improves generalization of statistical 
output. IBM SPSS® missing value analysis was used to detect trend in missing data for 
the independent variables. No systematic pattern was observed, such that missing 
information in the data may be random, and will not significantly contribute to trend in 
the model (Salkind, 2011). To correct for missing values, multiple imputation technique 
Scores of LPI  
survey period 
Average MDA  
coverage period 
2007 2006 , 2007 , 2008 
2010 2009, 2010, 2011 
2012 2011, 2012, 2013 




and exclude cases pairwise options were used to control for the effect of missing values I 
the analysis. 
Normality Assessment  
Most statistical techniques assume normality of distribution of variables (Salkind, 
2011). Several techniques are used to assess normality of distribution including 
histogram, boxplot, normal Q-Q plot and descriptive statistic – skewness, kurtosis, and 
Kolmogorov-Smirnov.  
  
Table 6  
Assessing Normality of dependent and independent variables 
Tests of Normality 
 Kolmogorov-Smirnova Normality Statistic 
Statistic df Sig. Skewness Kurtosis Std. Error 
Supply Chain Infrastructure .085 150 .010 .721 .458 .198 
Customs and Border Process .067 154 .088 .621 .615 .195 
Logistics Services .076 154 .032 .385 -.117 .195 
Supply Chain Reliability .103 154 .000 .381 .377 .195 
National MDA Coverage .141 164 .000 -0.036 -1.513 .190 
a. Lilliefors Significance Correction 
 
In addition to inspection of histogram, boxplot, normal and extrended normal Q-Q 
plots of the distributions, statistical test for normality revealed deviation of the dependent 
variables from normal distribution (Table 6). Skewness indicates symmetry of the 
distribution along dumbbell shape of a normal distribution curve. Positive skewness 
suggest scores are clustered to the left lower values; negative skewness suggest clusters 
around high scores. Kurtosis gives information on the peak of the distribution; positive 




distribution with too many extreme values (Pallant, 2013, p.59;  Tabachnick & Fidell, 
2013, p.80). On the other hand, Kolmogorov-Smirnov statistics gives normality of scores 
with a non-significant result (p > 0.05) indicates normality (Pallant, 2013). Form the 
result of this analysis (Table 6), the dependent variable’s Kolmogorov-Smirnov statistic 
is significant (p < 0.001), negative kurtosis (- 1.053) and negative skewness (skewness = 
-0.037), suggesting significant deviation from normality (Table 6). Therefore, the 
dependent variable was re-assigned from continuous to nominal variable as low MDA 
coverage (≤65%) and high MDA converge (≥65%).  
Outliers 
Extreme value outliers may affect the statistical significance of normal curve 
distribution. To determine extreme value outliers, graphs (histogram and boxplot) and 
statistic (5% Trimmed Mean) were used (Green & Salkind, 2011; Pallant, 2013). 
Observing shapes of normality curve of histograms of each independent variable - 
infrastructure, customs process, logistics services and supply chain reliability -  revealed 
no point deviation from the rest of the distribution; reflecting the absence of extreme 
value outliers. Accordingly, the independent variables approximate normality with no 
extreme outliers affecting statistical assumptions of the model. In addition, extreme value 
points are marked with an asterisk, *, on a boxplot, to indicate outliers with more than 
three-box-lengths away from the edge of the box (Figure 1). No case with asterisk was 
observed on the boxplot graph representing the absence of extreme value outliers in the 





Figure 1. Boxplot of independent variables showing outliers. 
 
The influence of outliers on statistical assumption can be confirmed with 
descriptive statistics. The statistic used is the 5% Trimmed Mean, which reflect changes 
in the central tendency of the distribution if outliers were removed. If 5% Trimmed Mean 
is very different from the  sample mean, then the outliers will impact the normality 
assumption of the model; the alternative  is true. Since there is minimal deviation 
between the sample and 5% trimmed means (Table 7), outliers are insignificant, and will 
not influence the statistical assumptions of the model. 
Table 7  

















2.34 2.33 0.01 
Logistics services 2.49 2.48 0.01 
Supply chain 
reliability 
2.58 2.57 0.01 
 
Data Analysis 
Multiple linear regression was used to test statistical association. Multiple linear 
regression enables the prediction of the association of multiple predictor variables with an 
outcome variable. Because the aim of the study was to explore the association between 
supply chain logistics indicators and the control of NTD, assumptions of linear regression 
was used as the basis of statistical analysis.  
Using the IBM® Statistical Package for Social Sciences (SPSS) software, student 
version 21, the following variables were created for analysis: 
Region: These are low-and-middle income economic regions: Africa Region 
(AFR), America Region (AMR), Eastern Mediterranean Region (EMR), South East Asia 
Region (SEAR), and Western Pacific Region (WPR). These are the five geographic 
regions with tropical climates that are home to one or more NTD.  
Country and country code: This represent low-and middle-income tropical region 




PopReqPCT: Population requiring preventive chemotherapy and transmission 
through mass treatment. This is total population, in each country, that are exposed to one 
or more NTD. 
PopTreatPCT: This is population, in endemic communities, that were treated with 
one or combination of preventive drugs (Ivemectine and/or Albendazole) to prevent 
lymphatic filariasis. 
Year: This is the logistics performance indicator survey period, which are 2007, 
2010, 2012 and 2014. 
MDACov: This is the mass drug administration coverage, also known as national 
coverage, which is the  population treated with PCT drugs, divided by the population 
requiring PCT in  each coverage year. This is a measure of success toward NTD control 
and eventual elimination.  
INFR: The supply chain logistics infrastructure capacity in the county. Scored 
between 1(low) and 5 (high); the higher the score, the stronger the supply chain 
infrastructure in the country.  
CUS: Custom and border procedures  reflect the speed of processing of goods at 
the points of entries. Scored between 1 (low) and 5 (high); high scores represents 
expeditious processes at the points of entries. 
SERV: Services is the availability of logistics services providers in the country. 
Scored as 1 (low) and 5 (high), it represents the quality of logistics services providers in 




RELI: Supply chain logistics reliability determines the ease of traceability of 
essential products from point of entry to the final consumer or patient. The higher the 
score (5), the more efficient logistics, and the lower the score (1), the less efficient.  
With these variables, IBM ® SPSS’s Transform, Analyze and Graph menus were 
used to transform variables, conduct statistical analysis, and create chart/graphs 
respectively to evaluate model assumption, univariate, bivariate and multivariate analysis. 
Statistical Assumptions 
Mullticollinearity and Singularity  
Mullticollinearity occurs when two or more predictor variables are highly 
correlated (r= 0.7 or above), making the estimation of regression coefficient unstable, 
which may inflate standard errors of the coefficients (Pallant, 2013; Salkind & Green, 
2011). Singularity, on the other hand, occurs when one predictor is a combination of 
multiple predictors, making the other predictor redundant in the model (Pallant, 2013). 
Mullticollinearity and singularity are shown as tolerance and variance inflation factor 
(VIF), in a regression model. Tolerance associates variability to each predictor and is 
calculated as 1-R2. VIF is the inverse of the Tolerance; the higher the Tolerance the lower 
the VIF and vice versa. Tolerance values of less than 0.1 or VIF values higher than 10 are 
indicative of mullticollinearity. Preliminary analysis shows the absence of 
mullticollinearity among the predictor variables (Table 8), because tolerance values were 
between 0.19 and 0.32 and VIF between 3.11 to 5.31; affirming the validity for the use of 





Table 8  
Test for mullticollinearity of predictor variables 
 
Normality, Linearity, outliers, 
homoscedasticity and independence 
of residual 
Regression model assumes 
normality, independence, and 
homoscedasticity of residuals. These were determined simultaneously from the normal 
probability plot (P-P) of the regression standard residual, scatter plot, Cook’s and Mahal 
distances of the multiple regression. Inspecting the residual plots, scatter plot and 
outcome statistics reveal no deviations from these assumptions, further validating the 
suitability of the use of regression model in this research. 
Effect size statistics 
Effect size is the strength of association between predictor and criterion variables, 
whether or not the association statistically significance (Salkind & Green, 2011). In 
regression analysis, effect size is determined by the Pearson product-moment correlation 
coefficient, R, and its squared, R2, which are strength and variability relations 
respectively. R ranges from 0 to 1; 0 means no linear relations and 1 implies perfectly 
correlated variables. R2 is the degree by which the variations in outcome is attributed to 
the predictor(s) in a linear relation (Salkind & Green, 2011). 
Model Collinearity Statistics 
Zero-order Tolerance VIF 
1 
(Constant)    
INFR .213 .221 4.527 
CUST .234 .313 3.193 
SERV .157 .188 5.306 




Statistical Significance and Hypothesis Testing 
Statistical significant of a model is tested using p-value, which is based on the 
assumption that null hypothesis (H0) is true (Gerstman, 2008). A significant statistic is 
surety of reliability of test, it is not an indication of the practical importance or decision 
making utilities of that result (Gerstman, 2008). Rather, it explains the role of random 
chance in the observed differences in the relations. For that matter, p-values greater than 
0.1 are not significant; but 0.01 ≤ p ≤ 0.05 are significant. Consequently, failing to detect 
statistical significant is not the same as saying there is no relationship between variables 
(accepting null hypothesis), it merely says that evidence is not enough to unequivocally 
reject the null hypothesis (Gerstman, 2008).  
MDA coverage for PCT 
Since the inception of the Global Program for the Elimination of Lymphatic 
Filariasis in 2000, the population requiring preventive chemotherapy increased 




Table 9  
Baseline characteristics of PCT population in LMIC, 2000 – 2013 













2000 12 135,377,200 2,932,265 3,810,780 70.93% 40.77% 
2001 22 709,406,476 25,895,967 32,018,984 77.55% 37.14% 
2002 32 1,361,063,705 91,717,535 107,976,969 75.46% 39.32% 
2003 36 1,365,519,154 103,602,120 137,630,855 72.87% 47.58% 
2004 36 1,373,818,069 356,630,049 570,539,058 74.66% 54.32% 
2005 41 1,632,378,490 437,763,390 683,124,214 73.85% 50.36% 
2006 36 1,636,856,054 702,212,284 1,271,325,926 77.58% 49.39% 
2007 42 1,782,825,827 554,991,252 762,687,049 74.04% 43.96% 
2008 37 1,740,001,822 502,737,840 697,144,592 73.68% 44.46% 
2009 36 1,226,750,799 485,820,549 642,625,272 75.50% 39.85% 
2010 33 1,240,636,180 484,367,054 655,941,539 74.45% 41.12% 
2011 36 1,247,430,289 559,355,495 772,595,909 73.48% 49.48% 
2012 32 1,211,551,251 612,140,284 830,549,776 75.49% 47.68% 
2013 36 1,116,807,973 493,898,474 672,201,746 78.24% 52.84% 
 
At the same time, the number of people treated, through mass drug admiration, 
with preventive chemotherapy and transmission (PCT) drugs increased from less than 3 
million in 2000 to nearly 500 million, 13 years later, representing less than 45% 




initiating mapping for the control of NTD rises across the years, from 12 at baseline to 58 
by 2013 (Table 9). 
Figure 2  
Thirteen years of MDA coverage in LMIC 
 
 
Whereas the population 
requiring PCT had increased 
exponentially, access to preventive 
treatment still remain under 65% 
required for total elimination of the 
disease (Figure 3). Possible reasons attributed to this trend as well as factors infleuecing 
the attainment of bechmarked coverage in LMIC will be discussed in Chapter 5. 
Table 10  
Distribution of NTDs in LMIC 
Descriptive Statistics 
Sub-Sahara Africa has the highest 
burden of NTD in LMIC accouting more than 
50% of endemic countries, with South-East 
Asia and Western Pacific regions contrubting 
additional 34% of endemicity, suggesting that 
efforts to eradicate NTD can be regionally targeted (Table 10). On the other hand, supply 
chain capacity indicators;- supply chain logistics infrastructure, custom and border 
 
Region Frequency Percent 
 
AFR 84 51.2 
AMR 16 9.8 
EMR 8 4.9 
SEAR 28 17.1 
WPR 28 17.1 




process, logistic services and supply chain reliability have mean scores of less than  3, 
sggesting lower supply chain capacity in developing countries in comparison with their 
developed couterparts (Table 11). 
Table 11  











Mean 2.33 2.34 2.49 2.58 
Std. Deviation .41 .34 .39 .42 
Minimum 1.40 1.58 1.53 1.57 
Maximum 3.56 3.37 3.46 3.58 
 
The average logisitics infrastructure in LMIC was 2.3, custom and border process 
2.3, logisitics services 2.5 and supply chain reliabilty at 2.6 respectively. Indicating that 
across LMIC, logisitics infrastructure, custom and border processes are comparatively 
lower than logisitics services and supply chain reliability. However, some LMIC have 
reasonably high logisitics perfomance indicators ( maximum score = 3.58), whiles others 
suffer from inadequate supply chain infrastructure (minimum score = 1.4), corresponding 
to endemic countries’ level of development. For instance, Malaysia, Thailand, and Brazil 
have seen substantial improvemets in logisitics and supply chain indicators (above 3.0), 





Supply Chain Infrastructure and MDA Coverage 
Research Question 1: Is there a relationship between supply chain infrastructure 
and NTD control in low- and middle-income countries, as measured by MDA coverage of 
PCT drugs? 
A bivariate linear regression analysis was used to explore relationship between 
supply chain logistics infrastructure and the control of NTD by MDA coverage in low-
and-middle-income countries. Preliminary analysis of the residual scatter plot and 
regression model summary predicted a linear association between supply chain 
infrastructure and control of NTD (Table 12).  
 
Table 12  






t Sig. 95.0% Confidence 
Interval for B 





(Constant) 11.76 14.09 
 
.84 .405 -16.09 39.62 
logistics 
infrastructure 
15.87 5.94 .214 2.67 .008 4.12 27.61 
a Dependent Variable: National MDA Coverage 
b Selecting only cases for which LPI survey year >= 2007 
 
The value of the Spearman’s Product Moment or Correlation Coefficient (r = 
0.214), indicates a moderate linear relations between MDA coverage and logistics 
infrastructure, suggesting that infrastructure linearly predicts the success of MDA 




National MDA coverage = 0.21 logistics infrastructure + 11.76 ….. Eq. 1  
and the 95% confidence interval (4.12 to 27.62), implies that the two variables are 
significantly related (r = 0.21, n = 150, p = 0.008). Additionally, 5% (R2 = 0.046) of the 
variance in the national MDA coverage is accounted for by its linear relations with 
supply chain logistics infrastructure in tropical countries.  
Customs and Border Processes and MDA Coverage 
Research Question 2: Is there a relationship between logistics services and NTD 
control in low- and middle-income countries, as measured by MDA coverage of PCT 
drugs? 
To determine the association between customs and border procedures and the 
control of NTDs, a linear regression analysis was conducted. There is statistically 
significant correlation between the two variables (Table 13), implying that as customs 
and border processes improves, national MDA coverage for the control of infectious 











t Sig. 95.0% Confidence 
Interval for B 





(Constant) -2.381 16.810 
 
-.142 .888 -35.592 30.830 
Customs and 
border processes 
21.595 7.108 .239 3.038 .003 7.553 35.638 
a Dependent Variable: National MDA Coverage 
b Selecting only cases for which LPI survey year >= 2007 
 
The covariate statistics F (1, 154) = 9.232, p < 0.01 and t (154) = 3.04, p < 0.01, 
are statistically significant at 95% confidence interval (7.55 to 35.64), implying there is a 
significant linear relationship between customs and border process and MDA coverage in 
the control of tropical diseases. The regression equation: 
 National MDA coverage = 0.24 Custom and border processes – 2.39 … Eq. 2  
with the  Pearson coefficient (r = 0. 24, n = 154, p < 0.01) further confirms the direct 
correlation between the two variables and that 6%  of the variation in MDA coverage is 
accounted for by expedited custom and border processes in low-and middle-income 
countries. 
Logistics Services and MDA Coverage 
Research Question 3:  
Is there a relationship between customs and border procedures, and NTD control 




Linear regression analysis was conducted to determine the relationship between 
logistics services and the control of tropical diseases in low and middle income countries, 
using MDA coverage. The regression model, and the residual scatter plot (shown in 
Figure 4), predicted that the two variables are linearly related, such that variations in 
logistics services correlates with MDA coverage. 
Figure 3  
Scatterplot showing the relationship between MDA coverage and logistics services 
 
 
However, the relationship between the two is statically insignificant (p = 0.078) at 
95% confidence interval (-1.26 to 23.44). Also, the Correlation Coefficient, r = 0.14, 
predicted lower linear strength in the correlation between logistics services and the 
control of NTDs. Further, the regression equation: 
 National MDA coverage = 0.14 logistics services + 11.1 …… …Eq. 3  
and F (1, 152) = 3.15, p > 0.01; t (152) = 1.8, p > 0.01 confirms that there is non-
significant linear relationship between logistics services and the control of neglected 




Supply Chain Reliability and MDA Coverage 
Research Question 4: Is there a relationship between supply chain reliability, 
and NTD control in low- and middle-income countries, as measured by MDA coverage of 
PCT drugs? 
To answer this question, a linear bivariate regression analysis was conducted 
between supply chain reliability and MDA coverage in developing countries. The model 
analysis of variance (ANOVA), shown in Figure 14, revealed statistically significant 
linear relationship between supply chain reliability and the control of tropical diseases. 
Table 14   
Model analysis of variance for the relationship between supply chain reliability and 
MDA coverage 
ANOVAa,b 
Model Sum of 
Squares 
df Mean Square F Sig. 
1 
Regression 3667.032 1 3667.032 4.037 .046c 
Residual 138057.920 152 908.276   
Total 141724.951 153    
a Dependent Variable: National MDA Coverage 
b Selecting only cases for which LPI survey year >= 2007 
c Predictors: (Constant), Supply chain reliability 
 
The predictor F (1, 152) = 4.04, p = 0.046 and the correlation coefficient (r = 
0.16, n = 152) suggest positive and significant relations between the two variables. 
Hence, supply chain reliability positively predict control of tropical disease, but the 
strength of this relations is weak and  account for only 2.6% of observed variations in 




 National MDA coverage = 0.2 supply chain reliability + 11.6 …. Eq. 4  
marginally predicts variations between predictor and the criterion variables.  
Logistics Performance Index and MDA Coverage 
A multiple linear regression analysis was conducted to determine whether supply 
chain capacity predict the control of neglected tropical disease by  MDA of PCI drugs 
coverage. In this case, supply chain capacity is the index of  supply chain infrastructure, 
custom and border processes, logistics services and supply chain reliability, known as the 
LPI, in low ad middle income tropical countries. The overall Pearson multiple correlation 
coefficient of the model is positively correlated (r = 0.27, n = 145, p = 0.02) indicating a 
direct linear relationship between logistics performance index  and the control of NTDs. 
It also shows that LPI is statistically significant (p < 0.05) at 95% confidence interval, F 
(4, 142) = 2.9, p = 0.02, and accounts for 7% of variation in MDA coverage. 
The relative strength and contribution of each predictor, independently and after 
controlling for all others is depicted in Table 15. None of the predictors in combination is 
statistically significant even though infrastructure and custom processes, and supply 
chain reliability were independently significant in their correlation with MDA coverage. 
Except for logistics services that is negatively correlated, the other three predictors 
positively correlate with MDA coverage. The multiple regression equation is therefore: 
MDA Coverage = 0.2 logistics infrastructure + 0.3 custom and border processes – 0.3 





Table 15  















14.95 12.52 .20 1.19 .23 
Customs and 
border processes 
22.64 12.75 .25 1.78 .08 
Logistics 
services 
-21.51 14.14 -.28 -1.52 .13 
Supply chain 
reliability 
4.27 10.05 .06 .42 .67 
 
On the basis of the multiple correlation, we may say that LPI or logistics capacity  
is  a useful predictor of MDA coverage of PCT drugs in the control and eventual 
elimination of NTDs. In addition, the result of bivariate analysis revealed that supply 
chain infrastructure, customs and border procedures and supply chain reliabilities are 
significant predictors of MDA coverage in developing countries. On the other hand, 
quality of supply chain service providers is not significant predictor of MDA coverage. 
However, failing to determine statistical significant does not mean that the predictor is 
irrelevant, but rather the sample size might not have been large enough to determine 
significant at that level of confidence. Hence conclusions can be drawn on the impact of 
supply-chain capacity and tropical disease control with mass administration of preventive 





Using linear regression analysis, it was predicted that each logistics performance 
indicator is linearly correlated to MDA coverage in the control of NTD in low-and 
middle-income countries. Individually, logistic infrastructure, customs and border 
processes, and supply chain reliability are statistically significant in predicting the control 
of NTD. On the other hand, quality of logistics service providers is statistically 
insignificant in relations to MDA coverage of PCT drugs. The overall logistics capacity, 
measured by logistics performance index is significantly associated with MDA coverage 
at 95% confidence level (p = 0.046), accounting for 7% variation in MDA coverage in 
the control of tropical diseases. This finding is expected to contribute to existing literature 
on the control of NTD in low-and-middle income countries. As the field of supply chain 
epidemiology developed, more empirical evidence in public health literature will be 
available to further enhance studies on the impact of supply chain on disease prevention. 
Chapter 5 discusses the contribution of this result to the scientific knowledge pool 
and to the overall strategic policy directions in the global efforts to eradicate NTD in 






Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
The purpose of this study was to investigate the relationship between supply chain 
logistics capacity and the control of NTDs in low-and middle-income countries. 
Specifically, the purpose was to explore whether supply chain infrastructure, logistics 
services, customs and border procedures and supply chain reliability were predictors of 
MDA coverage of PCT drugs in the control of lymphatic filariasis in endemic 
communities. 
The results indicated linear correlations between each of supply chain logistics 
indicators and the coverage of MDA in the control and transmission of tropical diseases. 
This suggests that supply chain logistics indicators predict control of  NTDs in low- and 
middle-income countries. Of the four logistics indicators, supply chain infrastructure, 
customs and border procedures, and supply chain reliability significantly predict the 
coverage of preventive chemotherapy drugs in low-and middle-income countries. 
Similarly, logistics services are statistically insignificant in predicting chemotherapeutic 
coverage for the control of tropical diseases. 
This chapter discusses the relevance of these findings, their contribution to body 
of knowledge, their limitations and the recommendations based on them.  
Interpretation and Discussion of the Findings 
Preventive Chemotherapy and Transmission Drugs Coverage 
There was an increased trend in the coverage  of effective preventive drugs for the 




than 700 million treatment doses of one or more preventive chemotherapy drugs in at-risk 
communities were delivered (see Table 9), which contributed to the substantial reduction 
in DALYs. This finding is consistent with earlier reports by the WHO on the success of 
PCT in the control of tropical diseases (WHO, 2014). Because of the devastating effect of 
lymphatic filariasis, which has social, economic and psychological consequences on 
individuals and communities, the increased trend in the coverage of preventive 
chemotherapy significantly contributes to achieving the Millennium Development Goals, 
which called for the elimination of neglected diseases by 2020 (Fenwick, 2012; Hanson 
et al., 2012; Linehan et al., 2011).  
Even though the trend in the distribution of preventive chemotherapy drugs  
increased , there was a disproportionate increase in number of endemic communities 
requiring treatments annually (see Table 9). This can be attributed to the growing 
evidence of PCT as effective prevention strategy in the global elimination of disease. As 
a result, more endemic communities were participating in the program, further 
confirming the need for improved coverage of PCT in developing countries. 
Nevertheless, annual PCT coverage remains below the 65% benchmarked for elimination 
(see Figure 3). For instance, of the countries that participated in the MDA mapping in 
2007, 2010, 2012 and 2014, approximately  22%, 34%, 44% and 51% attained the 
required 65% benchmarked MDA coverage (successful coverage) respectively, reflecting 
improvements in coverage towards global elimination by 2020. This finding compares  
with earlier studies, which revealed improved success of tropical disease control  as 




2013). Consequently, improved PCT coverage trends significantly contribute towards the 
global success in the elimination of tropical diseases (Cohen, Dibner, & Wilson, 2010; 
Hanson et al., 2012; Krentel, Fischer, & Weil, 2013). For this reason, structural and 
supply chain interventions that improve the coverage of preventive doses of PCT can lead 
to reduction in disabilities associated with lymphatic filariasis (WHO, 2013).  
Supply Chain Logistics in Developing Countries 
Supply chain logistics indicators remain relatively low in developing countries 
compared to their developed counterparts. For instance, the average scores (out of 5) for 
supply chain infrastructure, customs and border procedures, quality of logistics services, 
and supply chain reliability were 2.33, 2.34, 2.49 and 2.58 respectively (see Table 11). 
This places low income countries  at the bottom rank of the LPI scale (Arvis, Mustra, 
Ojala, Shepherd, & Saslavsky, 2014). In contrast, Singapore, Germany and Netherlands – 
developed countries – have consistently scored above 4.0 on all logistics indicators over 
the same period. The findings in this study are similar to earlier  works that related 
logistics performance indicators with country’s development, economic competiveness 
and  social development (Arvis et al., 2014; Guner & Coskun, 2012). As a result, 
improvements in logistics and supply chain are imperative in order to facilitate socio-
economic development and global competitiveness of low income countries (Iwanow & 
Kirkpatrick, 2009; Puertas, Martí, & García, 2014) .  
Supply Chain Infrastructure and Disease Prevention 
There was a direct significant correlation between supply chain infrastructure and 




0.046, p = 0.008). Therefore, strengthening supply chain infrastructure will significantly 
improve preventive chemotherapy coverage for the control tropical diseases in 
developing countries. Hence, using the Ecological Theory of disease prevention, this 
research demonstrated that supply chain infrastructures are significant predictors of 
nation’s health, particularly in resource-limited developing countries. The significant of 
this study is that, diseases prevention interventions can no longer neglect  supply chain 
infrastructure  as predictor of PCT coverage for the elimination of tropical diseases.  
In a similar study using the Ecological Theory, Cohen et al., (2000), identified 
ecological structures contributing to nation’s health as safe roads, transportation and 
vector control (Cohen et al., 2000). Also, using the LPI, Arvid et al., (2007, 2010, 2012 & 
2014) identified the significant of supply chain infrastructure on social, economic and 
trade facilitation in developing countries.  
Guner & Coskun (2012) performed regression analysis with LPI and concluded 
that logistics infrastructure predicts economic and social wellbeing in Organization for 
Economic Cooperation and Development (OECD) countries (Guner & Coskun, 2012). 
The authors argued that social predictors such as risky behaviors, democracy and human 
development, are ecological determinants of socioeconomic wellbeing of a 
country(Guner & Coskun, 2012). 
In contrast, the current study confirms that logistics and supply chain 
infrastructure are predictors of MDA coverage for preventive chemotherapy in the 
control of tropical infectious diseases in developing countries. Consequently, 




control interventions. Hence, this work revealed the  role of supply chain infrastructure in 
predicting not just the socio-economic competitiveness of developed countries, but also 
in disease prevention strategies of developing countries. Others have shown how  supply 
chain capacity improved on availability  of life-saving blood-bank inventories (Nagurney, 
Masoumi, & Yu, 2012), vaccines (Haidari et al., 2013), essential medicines (Chandani et 
al., 2012), and outbreak response (Mbohwa, 2010). Hence, this study contributes to 
Supply Chain Epidemiology by affirming the role of strengthened supply chain 
infrastructures as mitigating interventions in the control of tropical diseases in endemic 
countries. 
 Customs and Border Procedures and Disease Control 
There was a significant relationship between customs and border procedures and 
control of tropical diseases in developing countries (r = 0. 24, n = 154, p = 0.003). This 
relationship implies that as customs and border procedures  becomes expeditious or 
effective, so is the clearance and distribution of preventive chemotherapy in the control of 
NTDs. This finding is consistent with previously reported study by Wilson (2007) that 
expeditious customs and border processes facilitate trade and contribute to the 
availability of products that are sensitive to long and cumbersome customs procedures 
(Wilson, 2007). Hence, this finding affirms  the earlier reported observation that 
improved customs and border procedures significantly contributes to countries’ 
competitiveness (Wilson, 2007).  
Ari-Pokka & Johan, (2009) also reported that, socioeconomic development 




which further highlight the impact of customs and border procedures on the overall 
wellbeing of nations. However, with limited modernization of customs and border 
procedures in developing countries, with reliance  on obsolete infrastructure it is difficult  
for essential products (such as PCT drugs) to reach end-users at the right time (Ari-Pekka 
& Juha, 2009). 
Inasmuch as this study affirmed earlier studies by Wilson (2007) and Ari-Pekka & 
Juha (2009),  the current finding further predicted the significance of customs and border 
procedures to the coverage of preventive chemotherapy drugs in disease control. In 
preventive chemotherapy, anti-helminthic drugs – ivemectin, albendazole and others, are 
manufactured by international pharmaceutical companies (e.g. GlaxoSmithKline) outside 
developing countries, and donated to endemic countries, through WHO elimination 
program. However, it is the responsibility of recipient country to expeditiously distribute 
these pharmaceuticals from point-of-entry to hard-to-reach communities within the 
country. This requires speedy clearance processes, reliable transportation and supply 
chain infrastructure, which are inadequate thereby affecting the success of PCT coverage. 
As a result, control of tropical disease with preventive drugs, remain under threat with 
inefficient customs and border procedures in developing countries. 
Logistics Services and Disease Prevention 
Logistics services defined the quality and number of logistics service providers in 
the country. It evaluates the quality of transportation services delivered by road, rail, air, 




measures the performance of freight forwarders, logistics carriers, transportation agencies 
(air, rail, road and maritime) and other service providers along the supply chain.  
There was a statistically non-significant (r = 0.14, p = 0.078) correlation between 
logistics services and the control of tropical diseases; implying quality of logistics 
services providers does not significantly influence the coverage of preventive 
chemotherapy in disease control. However, the absence of statistical significance 
correlation does not limit the practical utilization of this indicator for policy decisions. Its 
practical implication is that the quality of logistics services providers is somewhat related 
to  disease prevention (r = 0.14), and hence improvements in the quality of providers may 
contribute to, albeit insignificant, to reducing the burden of tropical disease. In fact, Arvis 
et al., (2014) reported that clientele satisfaction was stronger in regions with quality 
service providers than those with lower quality of services (Arvis et al., 2014). 
Subsequently, improvements in the quality of rail, road, air and maritime logistics 
services providers will enhance the expeditious transport of PCT drugs to end-user which 
will contribute to achieving global goals. 
Supply Chain Reliability and Disease Prevention 
Supply chain reliability tracks the possible causes of shipments delays that is 
endogenous to countries’ systems and procedures. Possible causes of shipments delays 
were identified as informal monetary payments (bribes), compulsory warehousing and 
maritime transshipments, which are affecting the overall performance of domestic supply 
chain capacity in developing countries. In contrast to  developed countries with defined 




countries still rely on multiagency transactions and direct solicitation of services and fees 
(Haidari et al., 2013). Thus, developing countries continue to have lower scores on 
supply chain reliability compared to developed  nations, resulting in lower supply chain 
capacity for trade facilitation and disease prevention.  
There was weak statistically significant correlation between supply chain 
reliability and disease control (r = 0.16, p = 0.046), in endemic countries. As a result, 
improvements in supply chain reliability marginally influence  the control of tropical 
diseases in endemic countries. Nonetheless, leveraging on the experiences of developed 
countries, low-income countries can enhance the reliability of their supply chain if they 
eliminate informal monetary payments, introduce electronic transactions and streamline 
interagency bottlenecks.  
LPI and Disease Prevention 
The LPI is the combination of supply chain and logistics indicators used to assess 
the supply chain capacity of nations. Individually, these indicators measure specific 
strengths or weaknesses in  countries’ competitiveness in trade facilitation at national and 
international levels. Several studies have been conducted by the World Bank and the 
academia to relate LPI with trade facilitation, socioeconomic development, and human 
development indices (Arvis et al., 2014; Guner & Coskun, 2012; Puertas et al., 2014). 
Nevertheless, the application of LPI to control of  tropical diseases was minimally 
explored; hence this study aimed at contributing to this body of knowledge. 
Results from the multiple regression analysis revealed statistically significant (r = 




strength of the correlation index (r = 0.3) is higher than any of the individual indicator 
alone, implying synergic effect of the indicators as an index. Consequently, for 
developing countries to significantly control tropical diseases, strengthened supply chain 
capacity – infrastructure, customs and border procedures, logistics services and supply 
chain reliability – must attracts policymakers and researchers attention. 
When LPI was ranked among nations, developing countries had lower average 
scores across all indicators compared to their developed counterparts, which is a 
confirmation of the role of logistics capacity to national development (Arvis et al., 2012). 
Researchers have correlated LPI with human development index, international 
competitiveness, and social and economic factors, and have concluded that low LPI 
scores are related to lower socio-economic status in developing countries (Arvis et al., 
2014; Guner & Coskun, 2012; Puertas et al., 2014). 
Expanding on the application of LPI to disease prevention strategies, this study 
demonstrated  that LPI scores significantly impact the control of NTDs in low- and 
middle-income countries. Additional finding of this study is that endemic countries with 
improved supply chain capacity have experienced substantial reduction in the burden of 
NTDs. For instance, Malaysia and Thailand, which have consistently scored high on all 
logistics indicators, have reached their eradication benchmark, whereas Ethiopia, Guinea 
and Sierra Leone, with consistently lower LPI scores are yet to achieve eradication 
benchmarks. Further confirming the impact of supply chain capacity  in attaining global 




Limitation of the Study 
Data collection for MDA coverage was voluntary, and endemic countries were at  
different stages of PCT implementation creating gaps in the information reported to the 
central repository, making it difficult to attain statistically significant sample size for the 
criterion variable. However, the use of stratified purposeful sample as alternative to 
statistical sample technique still validates the reliability and subsequent generalization of 
this result (Pallant, 2013).  
The value of Spearman’s Correlation Coefficients (R) for this study, which ranges 
from 0.1 to 0.3 is interpreted as moderate correlation (Pallant, 2013), suggesting that 
other variables, which were not the focus of this research, may be contributory. Hence, 
this study is limited in claiming cause-and-effect relationship between supply chain 
capacity and disease prevention. 
Recommendations 
Policymakers should give consideration to supply chain infrastructure in 
developing strategies for controlling the burden of tropical diseases. In the application of  
preventive chemotherapy for the control of  tropical diseases, it is imperative that 
mitigating factors affecting the distribution and availability of preventive drugs are 
considered. The WHO’s five-point strategy for elimination highlighted  PCT, vector 
control, human-veterinary interface, provision of safe water and sanitation, and 
strengthened national capacity on NTD control was proposed (WHO, 2013) as important 
determinant of success. However, policies on structure capacity, social determinants of 




desired attention. For this reason, some researchers have called for the halting of 
overmedication of the population as the principal strategy to NTD control (Spiegel et al., 
2010). As shown in the current study, there exist relationships among supply chain 
infrastructure, logistics services, customs and border procedures, and supply chain 
reliability  and MDA coverage of PCT drugs, which further confirms the need to develop 
supply chain strategic policy towards global eradication by 2020. 
Research in developing Supply Chain Epidemiology as an area of study is highly 
recommended. From the current exploratory study, it became obvious that supply chain 
infrastructure can have significant impact disease control interventions in low and middle 
income countries. In 2006, the United States Government lunched a global supply chain 
project, the Supply Chain Management System, that has procured, and distributed over 
$10 billion worth of public health commodities to developing countries for over 5 million 
people requiring HIV treatment (PEPFAR 3.0 document, 2015). This project has 
collected substantial data and information on supply chain structures and challenges in 
developing countries. It is recommended that further research should be conducted using 
the collected  data to relate supply chain capacity to prevalence, disability or mortality of 
HIV/AIDS to validate the significant investment in supply chain system strengthening.  
Further research is recommended in Supply Chain Epidemiology to determine the 
relation between supply chain capacity and the prevalence of other communicable and/or 
non-communicable diseases including bed net distribution in malaria control, ARV 
distribution and HIV prevalence, directly observed therapy (DOT) for tuberculosis 




chain infrastructure capacity in the prevention, control and elimination of communicable 
and non-communicable diseases; the objective of Supply Chain Epidemiology. 
Practical recommendation for the control of tropical diseases is providing 
technical and financial support to underdeveloped economies on sustainable 
infrastructure development and poverty alleviation. NTD has been termed “disease of 
poverty” because of its association with underdevelopment, poor sanitation ad hygiene 
Hence, developing sustainable socio-economic structures in endemic communities will 
alleviate the unintended hardship of these communities and provides alternatives to 
economic, social, and environmental wellbeing that influence population health.  
Social Change Implications of this Research 
This research has individual, community, and global social implications. At the 
individual level, I continually share the outcome of this study on social media (LinkedIn), 
community of practitioners (Association of Public Health Logisticians), and peer-review 
journal, in order to advocate for policies, and interventions using concepts and theories of 
supply chain epidemiology. With this effort, a new body of knowledge is developed and, 
when enhanced, will contribute to the global scientific community on the application of 
supply chain theories and principles to epidemiological investigations. 
At the community level, availability of preventive chemotherapy drugs 
contributes to disease control, which eventually will lead to reduction in morbidity and 
mortality. Hence, there is value in identifying community-level mitigating factors that 
impact the distribution and availability of essential preventive drugs for the control of 




The global effort to eradicate NTD by 2020 is under threat if supply chain 
infrastructure is not adequately strengthened in developing countries. This research 
therefore provided practical quantitative evidence on the impact of supply chain on the 
control of tropical diseases. From this study, there is the need to develop global supply 
chain strategies as a way of enhancing the existing interventions in order to achieve 
global benchmarked coverage for the control of  tropical diseases in developing 
countries. 
Conclusion 
The objective of this study was to explore the role of supply chain indicators on 
the control of NTDs. The results of this study showed a linear correlation between supply 
chain infrastructure capacity and developing countries’ ability to reach global eradication 
targets for the control and eventual elimination of tropical diseases. As a result, 
strengthening supply chain capacity in developing countries, through technical and 
financial prepositions, will significantly enhance the availability of preventive 
chemotherapy drugs, which will eventually reduce transmission, improve social 
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Appendix A: Permission Letter from the World Bank 
Dear Farouk Umaru, 
In response to your request under AI3647, the World Bank would like to refer you 
to World Bank Open Data site for free and easy access to World Bank data and statistics. 
Through this website, users have access to databases, pre-formatted tables and reports. 
Additional tools, including search, provide simple methods to find indicators and data 
quickly, with download and visualization options. Data is organized by Country, Topic, 
and Indicators, available in English, Spanish, French, and Arabic. The full set of the 
World Bank’s indicators on development are also available in the Data Catalog with over 
2,000 time series indicators, for over 200 economies, and in many cases for over 50 
years. The range of topics covered includes: 
Agriculture and Rural Development 
Aid Effectiveness 
Economic Policy and External Debt 
Education 












Science & Technology 
Social Development 
Urban Development 
If you are unable to find data responsive to your request through the 
data.worldbank.org website, please send your query to data@worldbank.org or call the 
help desk at +202 473 7824. If you require additional information other than data, you 
can consult the following websites: 
Country pages – provides information on countries 
Topic Pages – provides information by topic 
Documents and Reports Database – provides full-text project documents, research 
and working papers 
Projects Database – provides information on projects and analytical and advisory 
services provided by the Bank 
Archives Oral History Program – provides firsthand accounts of important events 
by present and former World Bank staff 
ISAD(G) Finding Aids – provides more specific and historical information on a 
variety of topics 
If you still cannot find the information you are looking for, you are welcome to 
submit a new request on line through the World Bank’s website specifying the 






The World Bank 
www.worldbank.org/wbaccess 




Appendix B: WHO Permission to use copyright information 
Dear Mr. Umaru, 
Thank you for your request for permission to reprint and reproduce certain WHO 
copyrighted material. 
 
On behalf of the World Health Organization, we are pleased to authorize your request to 
reproduce the WHO materials as detailed in the form below, subject to the terms and 
conditions of the non-exclusive license below. 
If you have questions regarding this authorization, please contact 
permissions@who.int. 
  














WORLD HEALTH ORGANIZATION (WHO) 
Non-exclusive license to use selected WHO published materials 
  
You submitted a request, through WHO’s online platform, for permission to 
reprint and reproduce certain WHO copyrighted material (the “Licensed Materials”). This 
is a legal agreement (the “Agreement”) between you and WHO, granting you a license to 
use the Licensed Materials subject to the terms and conditions herein.  
  
Read this Agreement in its entirety before using the Licensed Materials. 
  
By using the Licensed Materials, you enter into, and agree to be bound by, 
this Agreement. 
This license is granted only for original materials belonging to WHO. If any 
part of the WHO published materials you wish to reproduce are credited by WHO 
to a source other than WHO, those materials are not covered by this Agreement and 
are not part of the Licensed Materials. You are responsible for determining if this is 
the case, and if so, you are responsible for obtaining any necessary permission from 
the source of those third-party materials prior to their use.  
  
If you enter into this Agreement on behalf of an organization, by using the 
Licensed Materials you confirm (represent and warrant) that you are authorized by your 




terms “you” and “your” in this Agreement refer to, and this Agreement applies to, the 
organization.  
  
WHO grants this license to you based on the representations and warranties 
you made in the license request you submitted through WHO’s online platform. If 
any of those representations and/or warranties are or become false or inaccurate, 
this license agreement shall automatically terminate with immediate effect, without 
prejudice to any other remedies which WHO may have.  
  
If you have questions regarding this Agreement, please contact 
permissions@who.int. 
  
1.    License. Subject to the terms and Conditions of this Agreement, WHO grants 
to you a worldwide, royalty free, non-transferable, non-sub licensable, non-exclusive 
license to use, reproduce, publish, and display the Licensed Materials in the manner and 
using the media indicated in the Permissions Request Form you submitted to WHO (the 
“Licensed Use”). This license is limited to the current edition of your publication. Future 
editions or a different use of the Licensed Materials will require additional permission 
from WHO. If your request includes translation into different languages, then non-





2.    Retained Rights. Copyright in the Licensed Materials remains vested in WHO, 
and WHO retains all rights not specifically granted under this Agreement.  
3.    Mandatory Acknowledgement. In every instance of the Licensed Use, you 
must make suitable acknowledgement of WHO, either as a footnote or in a reference list 
at the end of your publication, as follows: 
“Reprinted from Publication title, Vol /edition number, Author(s), Title of article / 
title of 
chapter, Pages No., Copyright (Year).” 
In addition, if the Licensed Materials originate from the WHO web site, you must 
also include the URL reference and the date accessed. 
Translations of the Licensed Materials should be attributed as follows:  
“Translated with permission of the publisher from Publication title, Vol /edition 
number, Author(s), Title of article / title of chapter, Pages No., Year.” 
4.    Altering or Modifying the Licensed Materials. As part of the Licensed Use, 
you may minimally alter or adapt figures and tables in the Licensed Materials to match 
the style of your publication. Any other alteration or modification of the Licensed 
Materials (including abbreviations, additions, or deletions) may be made only with the 
prior written authorization of WHO.  
5.    Appropriate and Prohibited Uses. You must use the Licensed Materials in a 
factual and appropriate context. You may not use the Licensed Materials in association 




limitation, in advertisements, product brochures, company-sponsored web sites, annual 
reports, or other non-educational publications or distributions. 
6.    No WHO endorsement. You shall not state or imply that WHO endorses or is 
affiliated with your publication or the Licensed Use, or that WHO endorses any entity, 
organization, company, or product.  
7.    No use of the WHO logo. In no case shall you use the WHO name or emblem, 
or any abbreviation thereof. Notwithstanding the foregoing, if the WHO name and/or 
emblem appear as an integral part of the Licensed Materials (e.g. on a map) you may use 
the name and/or emblem in your use of the License Materials, provided the name and/or 
logo is not used separately from the Licensed Materials.  
8.    No Warranties by WHO. All reasonable precautions have been taken by WHO 
to verify the information contained in the Licensed Materials. However, WHO provides 
the Licensed Materials to you without warranty of any kind, either expressed or implied, 
and you are entirely responsible for your use of the Licensed Materials. In no event shall 
WHO be liable for damages arising from your use of the Licensed Materials.  
9.    Your Indemnification of WHO. You agree to indemnify WHO for, and hold 
WHO harmless against, any claim for damages, losses, and/or any costs, including 
attorneys' fees, arising in any manner whatsoever from your use of the Licensed 
Materials or for your breach of any of the terms of this Agreement. 
10. Termination. The license and the rights granted under this Agreement shall 




WHO may terminate this license at any time with immediate effect for any reason by 
written notice to you.  
11. Entire Agreement, Amendment. This Agreement is the entire agreement 
between you and WHO with respect to its subject matter. WHO is not bound by any 
additional terms that may appear in any communication from you. This Agreement may 
only be amended by mutual written agreement of you and WHO.  
12. Headings. Paragraph headings in this Agreement are for reference only.  
13. Dispute resolution. Any dispute relating to the interpretation or application of 
this Agreement shall, unless amicably settled, be subject to conciliation. In the event of 
failure of the latter, the dispute shall be settled by arbitration. The arbitration shall be 
conducted in accordance with the modalities to be agreed upon by the parties or, in the 
absence of agreement, with the rules of arbitration of the International Chamber of 
Commerce. The parties shall accept the arbitral award as final. 
14. Privileges and immunities. Nothing in or relating to this Agreement shall be 
deemed a waiver of any of the privileges and immunities enjoyed by WHO under 





Appendix C: About Logistics Performance Index (LPI) 
Verbatim narrative about LPI from the World Bank website: 
Welcome to the LPI! The Logistics Performance Index is an interactive 
benchmarking tool created to help countries identify the challenges and opportunities 
they face in their performance on trade logistics and what they can do to improve their 
performance. The LPI 2014 allows for comparisons across 160 countries. The LPI is 
based on a worldwide survey of operators on the ground (global freight forwarders and 
express carriers), providing feedback on the logistics “friendliness” of the countries in 
which they operate and those with which they trade. They combine in-depth knowledge 
of the countries in which they operate with informed qualitative assessments of other 
countries where they trade and experience of global logistics environment. Feedback 
from operators is supplemented with quantitative data on the performance of key 
components of the logistics chain in the country of work. 
The LPI consists therefore of both qualitative and quantitative measures and helps 
build profiles of logistics friendliness for these countries. It measures performance along 
the logistics supply chain within a country and offers two different perspectives: 
international and domestic. 
International LPI 
Provides qualitative evaluations of a country in six areas by its trading partners—





Provides both qualitative and quantitative assessments of a country by logistics 
professionals working inside it. It includes detailed information on the logistics 





Appendix D: Example of 2014 LPI survey tool 
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